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I.  INTRODUCTION 
Portsmouth, Ohio is a small steel town with a big city problem.1  This city has 
been particularly hard hit by the prescription drug abuse epidemic.2  Nationally, the 
prescription abuse epidemic has killed more people than the crack cocaine epidemic 
of the 1980’s and the heroin epidemic of the 1970’s combined.3  In 2010, “9.7 
million doses of prescription painkillers were dispensed in Scioto County[, Ohio, or] 
123 doses for each of the 79,000 men, women and children in the county.”4  
Portsmouth counts its dead by lining the front window of a vacant department store 
with pictures of those who died due to overdosing.5  The city is essentially raising 
third and fourth generation prescription drug addicts.6  In one particularly 
disheartening instance, a local family could name eleven houses on their street that 
sold drugs.7  The majority of people who abuse these medications either get their 
drugs from dealers on the street or from someone who has access to these drugs.8  
The drug of choice—Oxycontin—is legal, and can be obtained from a local 
pharmacy with a prescription.9 Drug abuse there is so pervasive that, despite the high 
                                                            
 1 This Note frequently references Portsmouth, Ohio as a case study for the effects of 
ineffective legislation currently controlling in Ohio.  
 2 Sabrina Tavernise, Ohio County Losing Its Young to Painkillers’ Grip, N.Y. TIMES 
(Apr. 19, 2011), http://www.nytimes.com/2011/04/20/us/20drugs.html?_r=3&pagewanted=1; 
see also STATE MEDICAL BOARD OF OHIO, RESOLUTION REGARDING PRESCRIPTION DRUG 
ABUSE (2011), available at http://www.med.ohio.gov/pdf/PrescriptionDrug%20Abuse.pdf 
(“Between 1999 and 2008, there was a 360% increase in accidental over-dose deaths in Scioto 
County; 92% of these deaths are due to prescription medication.”). 
 3 See Tavernise, supra note 2. 
 4 See STATE MEDICAL BOARD, supra note 2; see also OHIO DEPARTMENT OF ALCOHOL 
AND DRUG ADDICTION SERVICES, OHIO’S OPIATE EPIDEMIC: 2010 PRESCRIPTION OPIATE 
CONSUMPTION PER CAPITA (2011), available at http://www.odadas.state.oh.us/public/ 
OpenFile.aspx?DocumentID=12f9370d-e022-48ee-ba0a-b688d21167a5 (documenting opiate 
consumption per capita in each of Ohio’s counties; Scioto, Ohio has one of the highest rates of 
opiate consumption). 
 5 See Tavernise, supra note 2. 
 6 See Tavernise, supra note 2. 
 7 See Tavernise, supra note 2; see also Prescription Drug Abuse – Prescription Drug 
Addiction, ATLANTA RECOVERY CENTER, http://atlantarecoverycenter.com/drugs-of-
abuse/prescription-drug-abuse/ (last visited Oct. 30, 2012) (explaining that Oxycontin is a 
highly addictive prescription drug and is fatal when taken in large doses). 
 8 See Tavernise, supra note 2. 
 9 See Controlled Substances – Alphabetical Order, OFFICE OF DIVERSION CONTROL, DRUG 
ENFORCEMENT ADMIN, U.S. DEP’T OF JUSTICE, http://www.deadiversion.usdoj.gov/schedules 
/orangebook/c_cs_alpha.pdf (last updated September 6, 2012) (listing Oxycodone, commonly 
known as Oxycontin, as a “Schedule II” substance). Schedule II substances can be prescribed 
by practitioners. Section V – Valid Prescription Requirements, OFFICE OF DIVERSION 
CONTROL, DRUG ENFORCEMENT ADMIN, U.S. DEP’T OF JUSTICE, http://www.deadiversion 
.usdoj.gov/pubs/manuals/pract/section5.htm (last visited Oct. 28, 2012). 
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unemployment rate,10 some businesses have difficulty finding job candidates who 
can pass a drug test.11 
While some parts of Ohio are affected more so than others by this prescription 
abuse epidemic,12 current legislation allows a situation, like that of Portsmouth, to 
happen anywhere in Ohio.  This is in large part due to Ohio’s statutory scheme that 
focuses more on punishment than prevention, despite recent encouraging changes 
that have been made.13  Despite the changes already in place, the legislature should 
enact a consequential solution that prevents prescription abuse by removing these 
drugs from the streets. 
Ohio has a system in place with the capability to curb prescription drug abuse, 
but it is far underutilized.14  The Ohio Automated Rx Reporting System (“OARRS”) 
currently tracks all controlled prescription medications dispensed by an Ohio-
licensed pharmacy.15  OARRS is “designed to allow physicians and pharmacists to 
cross-check prescriptions with each other and identify individuals who may be 
doctor shopping.”16  When using OARRS, physicians can more effectively serve as 
the gatekeepers to dangerous prescription medications because they have access to 
more information to make the best decisions regarding prescription choices for 
patients.17  But, currently, reporting from the system is not required in all situations, 
and before the recent changes of 2011, only a minority of practitioners were 
                                                            
 10 Local Area Unemployment Statistics, UNITED STATES DEPARTMENT OF LABOR, available 
at http://data.bls.gov/timeseries/LASST39000003 (Data extracted on Oct. 28, 2012) (Ohio’s 
unemployment rate for August, 2012 was 7.2%). 
 11 See Tavernise, supra note 2. 
 12 See OHIO DEPARTMENT OF ALCOHOL AND DRUG ADDICTION SERVICES, supra note 4 
(displaying opiate consumption per capita in each of Ohio’s counties). Although this map 
accounts for all opiate consumption, legitimate and illegitimate, it can be inferred that the 
incidence of illicit prescriptions would be more prevalent in areas with higher overall 
incidence rates of opiate consumption. See id. 
 13 See infra Part II.E (discussing the current state of Ohio law relating to prescription 
abuse, and the recent changes enacted by the Ohio Legislature to combat pill mills).  See also 
infra Part II.B (discussing the shortcomings of Ohio’s statutory system related to prescription 
drug abuse and prevention). 
 14 Ohio Sheriffs' Group Seeks Better Drug Monitoring, THE COLUMBUS DISPATCH (Jan. 20, 
2010)  http://www.dispatch.com/content/stories/local/2010/01/20/drug-monitor.html 
(reporting that before the recent changes in 2011, however, only 13% of Ohio’s 42,000 
doctors and dentists were registered to use this system).  
 15 See Ohio Rev. Code Ann. § 4729.75 (LexisNexis 2011) (granting the Ohio Board of 
Pharmacy authority to “establish and maintain a drug database . . . to monitor the misuse and 
diversion of controlled substances”).  Distributors of drugs include not only retail pharmacies 
located within the state, but also mail order pharmacies located outside of the state.  Ohio Rev. 
Code Ann. § 4729.77 (LexisNexis 2011) (“each . . . terminal distributor of dangerous drugs 
that dispenses drugs to patients in this state . . . shall submit to the board . . . prescription 
information” including patient information, prescriber identification, and prescription 
information such as drug, dosage, quantity, and days’ supply). 
 16 Doctor Shopping Chronic Pain Medication Addiction, DRUGADDITION.COM, 
http://www.drug-addiction.com/doctor_shopping.htm (last visited Oct. 28, 2012). 
 17 See id.  
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registered to use it.18  In response to the growing prescription drug abuse epidemic, 
the Ohio legislature enacted House Bill 93 on May 20, 201119 to eliminate “pill 
mills,”20 or a physician’s office that sells prescriptions under the table to anyone with 
cash.21 
Regardless of the positive effects with the enactment of H.B. 93, Ohio needs to 
take more action to prevent prescription abuse.  Ohio was at the cusp of tackling the 
prescription abuse epidemic, but fell short of the results it was capable of attaining.22  
Specifically, H.B. 93 falls short because it does not focus on prevention.23  Instead, 
H.B. 93 only gives OARRS the capability to identify clinics that supply patients with 
unnecessary quantities of medication.24  While this prevents some prescription abuse, 
it does not go far enough.  For instance, most physicians may use Ohio’s 
Prescription Monitoring Program (PMP), also known as OARRS, but only few 
physicians are required to do so.25  However, used to its full potential, OARRS can 
provide physicians with more information to identify drug-seeking behaviors of 
patients.26  
Also, H.B. 93 does not address other issues that facilitate drug abuse.27  One 
reason why prescriptions are so easily abused is because there are so many of them 
in the house.28  Another reason is that patients are not effectively held accountable 
                                                            
 18 See Ohio Sheriffs' Group Seeks Better Drug Monitoring, supra note 14. 
 19 See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at 
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93.  
 20 Russ Zimmer, Ohio Law Nixes Pill Mills, BUCYRUS TELEGRAPH F. (May 21, 2011), 
http://www.bucyrustelegraphforum.com/article/20110522/NEWS01/305220007/Ohio-law-
nixes-pill-mills.  
 21 What is a Pill Mill?, THE OFFICIAL BLOG SITE OF THE BAY AREA COUNCIL ON DRUGS & 
ALCOHOL, http://www.bacodablogs.com/2011/01/what-is-pill-mill.html (last visited Oct. 28, 
2012). 
 22 See OHIO STATE BOARD OF PHARMACY, OHIO’S DANGEROUS DRUG DATABASE PAST, 
PRESENT, AND FUTURE: HOUSE BILL 93 REPORT (2011) available at 
https://www.ohiopmp.gov/Portal/Search.aspx?searchText=past%2c+present%2c+future.   
 23 See infra Part III.B.2 (discussing the reactive nature of Ohio’s current prescription 
legislation). 
 24 See Doctor Shopping Chronic Pain Medication Addiction, supra note 16 (“[drug 
databases] allow physicians and pharmacists to cross-check prescriptions with each other and 
identify individuals who may be doctor shopping”). 
 25 See infra Part II.F (discussing the current state of Ohio’s laws vis-à-vis prescription 
reporting). 
 26 See OHIO STATE BOARD OF PHARMACY, supra note 22. 
 27 See H.B. 93, supra note 19. 
 28 See infra Part II.C. Part II.C discusses various sources of prescription drugs that are 
abused.  Although this Note identifies three unique sources (pill mills, doctor shopping, and 
the home), these sources are interrelated because prescriptions obtained either from doctor 
shopping or from a pill mill invariably end up in homes, where other persons can access them. 
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for doctor shopping.29 Thus, Ohio should mandate OARRS reporting and monitoring 
by all prescribers, promote OARRS interconnectivity with other states, mandate 
prescription return programs, and create stronger anti-doctor shopping statutes to 
effectively curb prescription abuse. 
Prescription abuse in Ohio continues to be a serious and complex issue that 
should be addressed. Accordingly, Part II of this Note examines the background of 
prescription drug abuse generally.  It identifies the dangers of prescription drug 
abuse, the cost drug abuse places on society, some reasons for prescription drug 
abuse, sources of prescription drugs, and discusses the current state and federal laws 
regarding prescription drug abuse and prescription reporting.  Part III discusses the 
positive and negative aspects of H.B. 93 and Medical Rule 4731-11-11 and then 
offers proposals to more effectively prevent prescription drug abuse.  Part IV 
discusses various criticisms of the current OARRS system and demonstrates why 
these concerns are either unfounded or do not outweigh the benefits of having such a 
system. 
II.  BACKGROUND  
Prescription drug abuse is a complicated topic with many facets.  To help 
understand the topic, it is necessary to discuss the dangers, costs, causes, and sources 
of prescription abuse, and to look at the relevant federal and Ohio statutes that 
pertain to prescription abuse.  Thus, Part A identifies the dangers of abusing opioids, 
tranquilizers, and stimulants—three of the most commonly abused classes of 
prescriptions.  Part B discusses the costs that prescription abuse places on society.  
Part C proffers various reasons for prescription drug abuse.  Part D identifies pill 
mills, doctor shopping, and the home as major sources of prescription drugs.  A brief 
description of the Controlled Substances Act, which regulates drugs at the federal 
level, can be found in Part E.  Finally, Part F provides an overview of the statutory 
scheme surrounding prescription drug abuse in Ohio. 
A.  Dangers of Prescription Drug Abuse 
The dangers of prescription drug abuse are well documented.  Prescription drug 
abuse is “the intentional use of a medication without a prescription; in a way other 
than as prescribed; or for the experience or feeling it causes.”30  The most commonly 
abused medications are pain relievers,31 tranquilizers,32 and stimulants.33  As will be 
                                                            
 29 See infra Part III.B.1 (discussing in part the shortcomings of Ohio’s anti-doctor shopper 
statute). 
 30 NATIONAL INSTITUTE ON DRUG ABUSE, PRESCRIPTION DRUG ABUSE (December, 2011), 
available at http://www.drugabuse.gov/sites/default/files/prescription_1.pdf.  
 31 “Opioids are commonly prescribed [as pain relievers] because of their effective 
analgesic, or pain-relieving, properties. Medications that fall within this class-referred to as 
prescription narcotics-include morphine (e.g., Kadian, Avinza), codeine, oxycodone (e.g., 
Oxycontin, Percodan, Percocet), and related drugs.” NATIONAL INSTITUTE ON DRUG ABUSE, 
PRESCRIPTION DRUGS ABUSE AND ADDICTION (2001), available at http://www.chce.research 
.va.gov/docs/pdfs/RRPrescription.pdf.   
 32 NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 33 NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
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discussed in more detail, the abuse of opioids, tranquilizers, and stimulants can have 
devastating effects on the human body. 
1.  Opioids 
“The term opiates refers to naturally occurring alkaloids, such as morphine, 
codeine, and thebaine . . . that are derived from the opium poppy plant.”34 Abusing 
opioids can be very harmful to the body.35  Opioid chemicals bind to the opioid 
receptors in the central nervous system36 and provide an analgesic effect because 
they decrease and alter the sensation of pain.37  Opioid abuse may lead to 
drowsiness, and may dangerously decrease the rate of breathing.38  Furthermore, “if 
combined with other medications that cause drowsiness or with alcohol, heart rate 
and respiration can slow down dangerously.”39  In addition, a person’s prolonged use 
of opioids can dull the effects of the drug because the body becomes tolerant of the 
drugs’ effects.40  Consequently, a person taking the drugs may increase their 
dosage.41 Finally, opioid addiction is most common in those who abuse these drugs 
recreationally, and the unpleasant withdrawal effects tend to reinforce the 
addiction.42  Ironically, the Ancient Sumerians referred to the opium plant as “hu gil” 
or “plant of joy,”43 perhaps alluding to its propensity for abuse.44 
                                                            
 34 Susan Y. Kim-Katz & Ilene B. Anderson, Prescription Opiate/Opioid Drug Abuse: A 
New Epidemic, THE AM. C. OF CHEST PHYSICIANS (Jan. 1, 2011), available at 
http://www.chestnet.org/accp/pccsu/prescription-opiateopioid-drug-abuse-new-
epidemic?page=0,3.  See also Transforming Opium Poppies into Heroin, PBS, 
http://www.pbs.org/wgbh/pages/frontline/shows/heroin/transform/ (last visited Oct. 28, 2012). 
 35 See Kim-Katz & Anderson, supra note 34.  
 36 How Do Opioids Work in the Brain?, THE NATIONAL ALLIANCE OF ADVOCATES FOR 
BUPRENORPHINE TREATMENT, http://www.naabt.org/faq_answers.cfm?ID=6 (last visited Oct. 
28, 2012). 
 37 Steve Richeimer & Susan Spinasanta, Drugs Used to Treat Pain: Opioids – Narcotics, 
SPINEUNIVERSE.COM, http://www.spineuniverse.com/treatments/medication/drugs-used-treat-
pain-opioids-narcotics (last updated on Feb. 1, 2010). 
 38 NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30; see also Opioid Side Effects, 
NEWS MEDICAL, http://www.news-medical.net/health/Opioid-Side-Effects.aspx (last visited 
Oct. 28, 2012) (“Although [respiratory depression] is the most serious adverse reaction 
associated with opioid use[, respiratory depression] usually is seen with the use of a single, 
intravenous dose in an opioid-naive patient.” Thus, the dangers of respiratory depression are 
most prevalent in those who take prescriptions on a recreational basis.). 
 39 What is Prescription Drug Abuse?, NATIONAL INSTITUTE ON DRUG ABUSE (AUG. 7, 
2012),  http://www.nida.nih.gov/researchreports/prescription/prescription2.html. 
 40 See generally Kathleen M. Foley, Changing Concepts of Tolerance to Opioids: What 
the Cancer Patient Has Taught Us, CURRENT AND EMERGING ISSUES IN CANCER PAIN: 
RESEARCH AND PRACTICE (1993), available at http://painresearch.utah.edu/cancerpain/ch20. 
html (evaluating the effects of drug tolerance in cancer patients). 
 41 Risks of Opiate Abuse, THE WAISMANN METHOD, http://www.opiates.com/opiate-
abuse.html (last visited Oct. 28, 2012). 
 42 See Opioid Side Effects, supra note 38.   
 43 Charles J. Fox III et al., Opioids: Pharmacokinetics and Pharmacodynamics, in 91 
ESSENTIALS OF PAIN MANAGEMENT (Nalini Vadivelu et al. eds., 2011); see also Kim-Katz & 
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Opioids also have indirect effects on the health of patients with a history of 
prescription drug abuse.45  For example, healthcare “providers tend to undertreat pain 
in this population due to biases, misconceptions, and systems issues.”46  Thus, when 
patients with a substance abuse history are actually in pain and need medicine, 
physicians fear that the patient is “crying wolf” in an attempt to secure more 
medication.47  This undertreatment results in “increased length of stay [at a hospital], 
frequent readmissions, and increased outpatient and emergency visits.”48  
Opioid abuse is so pervasive that it impacted nearly an entire generation of 
people living in southern Ohio.49  The most popular drug abused in Scioto County, 
Ohio, is an opioid by the name of Oxycontin.50  “Nearly 1 in 10 babies born last year 
in this Appalachian county tested positive for drugs.”51  The situation in Scioto 
County has been compared to the drug abuse epidemics of the 1970’s and 1980’s: “a 
generation of young people…were raised by their grandparents because their parents 
were addicts, and now they are addicts themselves.”52  The addiction to opioids 
creates such desperation that in some instances people will kill and commit other 
crimes to get access to Oxycontin.53  For instance, a local elderly man had access to 
Oxycontin prescriptions, and a burglar broke into his house to search for them.54  
                                                            
Anderson, supra note 34 (“The Sumerians first cultivated the opium poppy around 3400 BC 
and referred to it as Hul Gil, or the ‘joy plant.’”). 
 44 See Transforming Opium Poppies into Heroin, supra note 34. 
 45  Marian S. Grant et al., Acute Pain Management in Hospitalized Patients with Current 
Opioid Abuse, MEDSCAPE NEWS (June 6, 2007), http://www.medscape.com/viewarticle 
/557043_3. 
 46 Id.; see also Pain Management and Addiction, TREATMENT-CENTERS.NET (July 25, 
2012), http://www.treatment-centers.net/pain-management-and-addiction.html. 
 47 Pain Management and Addiction, supra note 46. 
 48 See Grant, supra note 45. 
 49 See generally Tavernise, supra note 2 (describing Portsmouth’s plight with prescription 
abuse).   
 50 Id. 
 51 Id. 
 52 Id.; see also Grace Wyler, Obama, GOP Govs., Want More Spending To Fight 
OxyContin Epidemic, BUS. INSIDER, (Apr. 20, 2011), http://articles.businessinsider.com/2011-
04-20/politics/30002690_1_prescription-drug-abuse-overdoses-oxycontin-first (“Prescription 
drug abuse has long been a scourge across Appalachia, claiming more lives than the '80s crack 
epidemic and the '70s heroin epidemic combined, [as reported by the Tavernise article, supra 
note 2].”). 
 53 See Frank Lewis, Two Found Fatally Shot in Lucasville, PORTSMOUTH DAILY TIMES, 
(Jan. 11, 2010, 12:00 AM), http://www.portsmouthdailytimes.com/pages/full_story/push? 
articleTwo+Found+Fatally+Shot+In+Lucasville%20&id=5510425&instance=secondary_new
s_left_column; see also Julian Borger, Hillbilly Heroin: The Painkiller Abuse Wrecking Lives 
in West Virginia, THE GUARDIAN (June 24, 2001), http://www.guardian.co.uk/world/2001 
/jun/25/usa.julianborger (“The OxyContin epidemic has meanwhile generated an exponential 
rise in the crime rate, as addicts become ever more desperate to finance their craving.”). 
 54 See Tavernise, supra note 2. 
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This burglar then killed the man and the woman he was living with, while the 
woman’s young daughter watched.55 
2.  Tranquilizers 
Another drug that is readily available and can be dangerous when abused is 
tranquilizers.56  Tranquilizers are commonly prescribed as anti-anxiety medications 
and sleep aids, and are part of the group of drugs known as depressants.57  
Tranquilizers include Xanax, Valium, and Ativan.58  Tranquilizers operate by 
inducing a feeling of calm or well-being.59  Also, combining an opioid with a 
depressant, such as a tranquilizer, can have dangerous health effects; for example, a 
user’s heart rate and breathing may decrease to a dangerous level.60  Combining 
tranquilizers with alcohol or opioids will similarly decrease the taker’s heart rate to a 
dangerous level.61  But unlike opioids or tranquilizers, alcohol does not require a 
prescription and is commonly found in many households. 
One of the most-publicized instances of overdose of tranquilizers was the recent 
case of Michael Jackson.62  A lethal cocktail of Propofol, Lorazepam, and 
Midazolam caused Michael Jackson’s death.63  On June 25, 2009, the artist who gave 
us such masterpieces as “Thriller,” “Billy Jean,” and “The Man in the Mirror” went 
into cardiac arrest in his mansion in Los Angeles, California.64  Subsequent attempts 
                                                            
 55 Id.; see also Lewis, supra note 53. 
 56 Tranquilizers, INSTITUTE FOR SUBSTANCE ABUSE TREATMENT EVALUATION, http://www.i 
sate.memphis.edu/tranquilizers.html (last visited Oct. 28, 2012). 
 57 Id. 
 58 Id. 
 59 Id. 
 60 See supra Part II.A.1 (describing harmful side effects on the body when opioids are 
combined with tranquilizers). 
 61 See supra Part II.A.1. 
 62 See Katherine Harmon, What is Propofol—and How Could It Have Killed Michael 
Jackson?, SCI. AM., (Oct. 3, 2011), http://www.scientificamerican.com/article.cfm?id= 
propofol-michael-jackson-doctor. 
 63 See id. (explaining that Propofol is a hypnotic that is used to induce general anesthesia); 
Lorazepam, NATIONAL CENTER FOR BIOTECHNOLOGY INFORMATION, http://www.ncbi.nlm. 
nih.gov/pubmedhealth/PMH0000560/ (last revised Oct. 1, 2010) (Lorazepam is a 
benzodiazepine used to treat anxiety); Midazolam, NATIONAL CENTER FOR BIOTECHNOLOGY 
INFORMATION, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000482/ (last revised Nov. 
1, 2010) (“Midazolam is given to children before medical procedures or before anesthesia for 
surgery to cause drowsiness, relieve anxiety, and prevent any memory of the event.”); 
Benjamin C. Wedro, Michael Jackson’s Death: Propofol (Diprivan) FAQ, MEDICINE.NET, 
http://www.medicinenet.com/script/main/art.asp?articlekey=113188 (last editorial review 
Nov. 8, 2011) (discussing that Michael Jackson’s death was caused by Propofol, Lorazepam, 
and Midazolam taken together). 
 64 Shulamit Shvartsman, What Caused Michael Jackson’s Sudden Death?, LAWYERS.COM, 
http://product-liability.lawyers.com/Product-Liability/What-Caused-Michael-Jacksons-
Sudden-Death.html (last visited Aug. 29, 2012); Michael Jackson’s Life Cut Shockingly Short, 
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to resuscitate him by his personal physician, paramedics, and the personnel at a 
hospital emergency room were unsuccessful.65  Over an hour after going into cardiac 
arrest, Michael Jackson was pronounced dead at Ronald Reagan University of 
California at Los Angeles Medical Center.66  The medications that caused Michael 
Jackson’s death were prescribed and administered to him by his personal physician.67  
Although tranquilizers have a common use—such as treating insomnia—they can be 
dangerous, and thus, their abuse needs to be controlled.68 
3.  Stimulants 
Similar to tranquilizers, stimulants have a common household use, and are also 
easily abused.69  Common prescription stimulants include Adderall, Ritalin, and 
Concerta.70  These drugs are typically used to treat Attention Deficit Hyperactivity 
Disorder (ADHD).71  But, ADHD drugs are a Schedule II narcotic, and thus, have a 
“limited medical purpose, with a high potential for abuse.”72  Because these drugs 
facilitate a better ability to concentrate, college students frequently abuse them in an 
effort to keep up with a heavy class load.73  Students consider the effects of these 
drugs so beneficial that, according to a 2002 University of Wisconsin study, “20 
percent of college students have used Adderall or Ritalin without a prescription.”74  
Students who use these drugs often say that the drugs helped them finish their work 
and remain focused.75 
Despite the perceived benefits of stimulant abuse, these drugs have severe 
medical consequences.  Side effects include dry mouth, lack of hunger, insomnia, 
                                                            
MSNBC, http://today.msnbc.msn.com/id/31552029/ns/today-entertainment/t/michael-
jacksons-life-cut-shockingly-short/#.TrXN63JRQW0 (last visited Oct. 28, 2012). 
 65 Shvartsman, supra note 64. 
 66 Michael Jackson’s Life Cut Shockingly Short, supra note 64. 
 67 See Wedro, supra note 63. 
 68 See Tranquilizers, supra note 56. 
 69 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 70 See generally Peter R. Breggin, Adderall Ritalin Concerta Side Effects in Adults and 
Child Medication, NATIVEREMEDIES, http://www.nativeremedies.com/articles/concerta-ritalin-
adderal-side-effects.shtml (last visited Oct 28, 2012) (describing use and effects of commonly 
prescribed ADHD stimulants). 
 71 Id. 
 72 See generally 21 U.S.C.S. § 812 (LexisNexis 2011) (describing the different schedules 
of drugs); see also Controlled Substances – Alphabetical Order, supra note 9 (depicting a list 
of various controlled substances, of which Amphetamine (Adderall) and Methylphenidate 
(Ritalin) are listed as Schedule II drugs). 
 73 Kelsie Smith, Dangers of Stimulant Abuse, THE U. DAILY KANSAN, (Feb. 2, 2006), 
http://kansan.com/archives/2006/02/02/dangers-of-stimulant-abuse/.  
 74 Id. 
 75 Id. 
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nausea, and addiction.76  Death can result in some cases when primary use of the 
drug causes “exploded blood vessels in the brain, heart attack, or dangerously 
elevated body temperature.”77  Further, because these drugs cause insomnia, a patient 
may begin abusing depressants to help themselves sleep.78  Consequently, uppers in 
the morning, and downers at night.79  Interestingly, many students who take Adderall 
may not realize that the chemical name of this drug is “amphetamine.”80  Further, 
“[o]ne of the easiest ways to make methamphetamine is from amphetamine.”81  
Thus, an increase in the amount of Adderall available on the street may lead to 
increased quantities of methamphetamine on the street.82  Stimulants, similar to 
tranquilizers, have a common medical use, but they are still dangerous.83  Thus, their 
use needs to be controlled to prevent abuse. 
B.  Costs of Prescription Abuse 
In addition to the dangerous health effects of prescription abuse, drug abuse also 
has a high cost on society.  Firstly, accidental drug overdose is the leading cause of 
accidental deaths for Ohioans since 2007.84  Furthermore, these “[f]atal and non-fatal 
poisonings [with prescription drugs] cost Ohioans $3.6 billion annually.”85  
Exacerbating the costs of prescription abuse, the “Ohio Substance Abuse Monitoring 
(OSAM) Network report[ed] a move from prescription painkillers to heroin among 
opiate abusers” and found that that “heroin is highly available in all regions of the 
state.”86  Heroin abuse places additional costs on citizens.  These costs are initially 
                                                            
 76 See Side Effects of Prescription Stimulants, STEADYHEALTH.COM, http://www. 
steadyhealth.com/articles/Side_effects_of_prescription_stimulants_a674.html (last visited 
Oct. 28, 2012); What are Amphetamines?, INFO DRUG REHAB , http://www.info-drug-
rehab.com/amphetamines.html (last visited Oct. 28, 2012). 
 77 See What are Amphetamines?, supra note 76. 
 78 See InfoFacts: Prescription and Over-the-Counter Medications, NATIONAL INSTITUTE 
ON DRUG ABUSE, http://www.drugabuse.gov/publications/drugfacts/prescription-over-counter-
medications (last revised May, 2012). 
 79 “‘Downers’ in the evening and ‘uppers’ in the morning may be regarded as part of a 
popular entertainer’s professional equipment, as well as an occupational health hazard for the 
profession.”  Thomas Szasz, Who Killed Michael Jackson?, THE FREEMAN (Mar., 2012), 
http://www.thefreemanonline.org/columns/the-therapeutic-state/who-killed-michael-jackson/. 
 80 See Breggin, supra note 70. 
 81 Methamphetamine Frequently Asked Questions, THE VAULTS OF EROWID, http://www. 
erowid.org/chemicals/meth/meth_faq.shtml (last updated Jan., 2005). 
 82 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30 (“Between 1991 and 2010, 
prescriptions for stimulants [such as Adderall] increased from 5 million to 45 million.”  Thus, 
if there was a nine-fold increase in the amount of prescriptions written for stimulants in the 
last 20 years, it can be inferred that there is a nine-fold increase in the amount of stimulants 
that can be available to make methamphetamine, as compared to 20 years ago.). 
 83 See generally supra Part II.A.2 (describing the dangers of tranquilizer abuse). 
 84 STATE MEDICAL BOARD OF OHIO, supra note 2. 
 85 Id. 
 86 Ohio’s Opiate Epidemic, OHIO DEPARTMENT OF ALCOHOL AND DRUG ADDICTION 
SERVICES (July, 2011), 
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borne by law enforcement and the criminal justice system, which must combat 
illegal heroin abuse, and these costs then forwarded to the taxpayers. 87  Put bluntly, 
because Ohioans cannot afford to tolerate prescription drug abuse, Ohio needs to 
step up to the plate and better combat prescription abuse. 
C.  Reasons for Prescription Drug Abuse 
Despite the inherent danger and costs of abuse, there are many reasons why 
people abuse prescription drugs.  Some people assume that a drug is safe because it 
is available through a prescription.88  This is not necessarily true.89  Some people 
abuse these drugs because they are readily available.90  In fact, “[b]etween 1991 and 
2010, prescriptions for stimulants increased from five million to forty-five million, a 
nine-fold increase, and opioid analgesics increased from about thirty million to one-
hundred-eighty million, a six-fold increase.”91  Other people abuse prescription drugs 
for their performance-enhancing capabilities.92  Still others abuse these drugs to feel 
the effect of the drug, to get high, or to ameliorate stress.93  For instance, injecting or 
snorting opioids elicits “a warm, floating feeling. Some say they feel pleasantly 
numb.”94  Given the diverse reasons for prescription drug abuse, a solution that can 
address each of these reasons is needed. 
D.  Sources of Prescription Drugs Used for Abuse 
Despite the inherent costs and dangers of prescription drug abuse, these drugs are 
readily available.  Prescription drugs are readily available through pill mills, doctor 
shopping, and can even be found in the home.95  As shown below, the ease through 
which controlled drugs can be accessed needs to be addressed. 
1.  Pill Mills 
Pill mills are only one piece to the puzzle of prescription drug abuse.  A pill mill 
is a “doctor, clinic or pharmacy that is prescribing or dispensing powerful 
                                                            
http://www.odadas.state.oh.us/public/OpenFile.aspx?DocumentID=e934f58b-74cf-4e1c-b2a0-
52eca5f6c271, see also infra Part II.D.2 (further detailing the costs and dangers that 
prescription drug abuse and heroin abuse places on the individual as well as society). 
 87 Id. 
 88 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 89 See generally supra Part II.A (describing the dangers of prescription drug abuse). 
 90 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 91 See id. These increases demonstrate that the amount of drugs available to the general 
public has increased dramatically over the last two decades. Id. 
 92 See generally supra Part II.A.3 (describing the phenomenon of college students abusing 
stimulants, such as Adderall or Ritalin to cope with a difficult class load).   
 93 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 94 Rachel Dissell, Overdose Deaths Climb as Painkillers, Heroin Pour into Ohio Market, 
THE PLAIN DEALER (Feb. 20, 2011, 6:00 AM), http://blog.cleveland.com/metro/2011/02/ 
overdose_deaths_climb_as_paink.html. 
 95 See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
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[prescription] narcotics inappropriately or for non-medical reasons.”96  Pill mills 
generally operate as cash-only pain management clinics.97  Pill mills also tend to 
open and close down quickly to evade law enforcement.98  They are characterized by 
long waits in line, and sometimes an absence of a single consultation with a 
physician.99  Patients are frequently invited to “pick their poison” by indicating 
which medication they want, with no questions asked by the physician.100  Physicians 
at these clinics rarely, if ever, explore alternative pain management techniques, and 
treat with pain pills only.101  The patient is then given a prescription for the drug of 
their choice.102 If the patient does not receive the drug immediately in the office, they 
are directed to a “preferred” pharmacy that will fill the prescription without issue.103   
The danger of pill mills goes far beyond harm to the health of an individual 
patient.  For example, if a patient visits multiple pill mills,104 they can amass a large 
quantity of drugs.105  Patients can then consume drugs from this collection as they 
wish or sell them on the street, which presents a hazard to the community.106  
Another identified harm, beyond the harm to the individual patient, occurs when 
patients fill their prescription in another state. In such cases the state where the pill 
mill is located will have difficulty identifying prescription drug abuse.107 
                                                            
 96 Pia Malbran, What’s a Pill Mill?, CBS NEWS (May 31, 2007 6:01 PM), 
http://www.cbsnews.com/8301-501263_162-2872835-501263.html. 
 97 What is a Pill Mill?, supra note 21. Since pill mills operate as a cash-only business, 
insurance companies cannot monitor patient drug use. Id. Insurance companies will often 
monitor the drugs a patient receives, and refuse to pay for a drug if the patient recently had 
this medication filled, and still should have some medication left.  Thus, it is difficult for the 
patient to amass a large supply of drugs.  See Fighting the Scourge of Pill Mills, CBS NEWS 
(Oct. 16, 2011 9:35 AM), http://www.cbsnews.com/stories/2011/10/16/sunday/main 
20121033.shtml (characterizing pill mills as a cash-only operation). 
 98 See Malbran, supra note 96.  
 99 What is a Pill Mill?, supra note 21. 
 100 Id.; Malbran, supra note 96. 
 101 What is a Pill Mill?, supra note 21; Malbran, supra note 96. 
 102 See Malbran, supra note 96 (identifying one of the signs of a pill mill as the patient 
picking their own medication, no questions asked). 
 103 What is a Pill Mill?, supra note 21; Malbran, supra note 96. 
 104 See infra Part II.D.2 (discussing doctor shopping as a source for medications to abuse). 
 105 In one instance, a patient in Georgia obtained a five-year supply of Oxycontin in one 
year by visiting dozens of pharmacies and almost sixty different doctors, and these drugs were 
paid for by taxpayers because the patient’s medications were covered by Medicare. See Robert 
Lowes, ‘Doctor-Shoppers’ Get Pain Meds at Medicare’s Expense, MEDSCAPE NEWS TODAY 
(October 26, 2011), http://www.medscape.com/viewarticle/752340. 
 106 See infra Part II.D.ii (discussing the dangers inherent in drugs sold on the street). 
 107 See generally infra Part III.C.2 (discussing the interconnectivity of the OARRS system 
and its ability to interface with the patient prescription databases of other states). 
2013] PHARMAGEDDON: A STATUTORY SOLUTION 115 
 
2.  Doctor Shopping  
Another source of collecting medications for abuse is the process known as 
“doctor shopping.”108  Doctor shopping is the process of receiving treatment from 
multiple physicians concurrently.109  These physicians often do not know that the 
patient is receiving treatment from other physicians.110  Doctor shoppers will often 
visit multiple physicians until they receive a prescription for their “preferred” 
drug.111  Doctor shoppers will visit physicians that they do not know to further mask 
their true intent.112  This process results in overmedicating patients; for example, a 
patient receiving Oxycontin from one physician may receive the same drug from 
another physician.113   
The danger of doctor shopping is exacerbated by the existence of pill mills.114  
The patient who “shopped” for the medication at multiple pill mills can either use 
the drugs from the resulting horde of medications, or sell them for a profit.115  
Oxycontin can sell for approximately $0.50 to $1/mg on the street.116  Thus, a single 
40mg pill of Oxycontin can sell for $20 to $40 illicitly.  To make matters worse, the 
price of a 40mg pill of Oxycontin purchased legally from a pharmacy is $4/pill.117  
Therefore, given a prescription for 90 pills of Oxycontin (1 pill, three times a day), a 
patient will pay $360 for the prescription, assuming the patient’s insurance is not 
involved.118  This same prescription can be sold on the street for $1,800 to $3,600.  
                                                            
 108 See Lowes, supra note 105. 
 109 David L. Robinson, Note & Comment, Bridging the Gaps: Improved Legislation to 
Prohibit the Abuse of Prescription Drugs in Virginia, 9 Appalachian J. L. 281, 289 (2010). 
 110 Id. 
 111 Id. 
 112 See Madison Park, How Physicians Try to Prevent ‘Doctor Shopping’, CNN HEALTH 
(Apr. 7, 2010), http://articles.cnn.com/20100407/health/doctor.shopping.haim_1_prescription-
drugs-xanax-doctor-shopping?_s=PM:HEALTH. 
 113 See id. Doctor shoppers will try various ways to obtain more medication.  In addition to 
visiting multiple doctors, shoppers will “call during weekends [presumably when the doctor 
does not have his or her record on hand] or ask for prescription refills using excuses such as 
having dropped the pills in toilets or getting pills wet on a camping trip.” Id. See also Sara 
Jane Tribble, Ohio Lawmakers Want to Mandate Prescription Monitoring by Doctors, THE 
PLAIN DEALER, (Jan. 20, 2010), http://www.cleveland.com/healthfit/index.ssf/2010/01 
/lawmakers_want_to_mandate_pres.html (“If doctors were required to check the database, 
they would spot patients who were pill shopping, going to multiple pain clinics and 
emergency rooms to obtain prescriptions or samples.”). 
 114 Doctor shoppers can quickly amass a large quantity of drugs.  This quantity would 
likely increase where the patient visits a pill mill that readily hands out medications with no 
qualms.  See Lowes, supra note 105. 
 115 Id. 
 116 OxyContin Diversion and Abuse, THE NATIONAL DRUG INTELLIGENCE CENTER (Jan. 
2001), http://www.justice.gov/archive/ndic/pubs/651/abuse.htm. 
 117 Id. 
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Combine this absurd profit margin with a high unemployment rate,119 and it is easy 
to see why patients could be tempted to “shop” for Oxycontin to supplement their 
income.120 
These high costs have other negative impacts.  For example, those who can no 
longer afford the street price of Oxycontin may be pushed to use heroin,121 which is 
available in many parts of the country.122  Both heroin and Oxycontin are opioid 
derivatives123 and therefore, they provide similar effects.124  Currently, the cost of 
heroin is around $172/gram, or $0.17/mg.125 Compare this price to the street price of 
Oxycontin at a minimum of $20 for a 40mg pill,126 and an abuser’s decision to 
switch from Oxycontin to heroin makes financial sense, if nothing else.127   
Heroin abuse is not a problem limited to the inner-city.128  Deaths related to this 
drug are increasing in Ohio’s affluent suburbs, such as Independence, where four 
persons overdosed on heroin in less than eight weeks.129  Switching from Oxycontin 
to heroin can be more dangerous; heroin may be laced with other chemicals because 
it is unregulated by the government.130  In addition, an addict who abuses heroin 
places additional costs on law enforcement agencies, and ultimately the taxpayer.131  
Ohio cannot afford to pay these costs.  Thus, combating Oxycontin abuse, whether 
                                                            
 118 If the patient’s insurance company is kept out of the loop with the medications a patient 
receives, then it will be easier for patients to get multiple prescriptions of the same 
medication.  See What is a Pill Mill?, supra note 21. 
 119 Local Area Unemployment Statistics, supra note 10. 
 120 See Borger, supra note 53 (“[Law enforcement officers are] trying to do [their] best to 
combat the dealers, who are often families on welfare trying to earn extra money.”). 
 121 OxyContin Diversion and Abuse, supra note 116. 
 122 Ohio’s Opiate Epidemic: User Profiles, supra note 86. 
 123 NIDA InfoFacts: Heroin, NATIONAL INSTITUTE ON DRUG ABUSE, http://www.nida.nih. 
gov/infofacts/heroin.html (last updated Mar. 2010). 
 124 See Dissell, supra note 94. 
 125 OFFICE ON DRUGS AND CRIME, UNITED NATIONS, 2008 WORLD DRUG REPORT 257 
(2008), available at http://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_ 
web.pdf. 
 126 Oxycontin on the street can sell for approximately $0.50 to $1/mg.  Thus, a single 40mg 
pill of Oxycontin can sell for $20 to $40 on the street.  See OxyContin Diversion and Abuse, 
supra note 116. 
 127 See Dissell, supra note 94. 
 128 See Dissell, supra note 94. 
 129 Tracy Carloss, Independence Bands Together to Fight Heroin After Four Overdoses in 
Eight Weeks, WEWS NEWS CHANNEL 5 (Jun. 16, 2006), http://www.newsnet5.com/dpp/news/ 
local_news/oh_cuyahoga/independence-bans-together-to-fight-heroin-after-4-overdoses-in-8-
weeks. 
 130 See Christian Nordqvist, Fentanyl-laced Heroin Kills Hundreds Of Addicts in USA, 
MED. NEWS TODAY (June 16, 2006), http://www.medicalnewstoday.com/articles/45391.php. 
 131 See generally supra Part II.B (describing the costs that prescription abuse places on 
society). 
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due to doctor shopping or other causes, will have the positive side effect of 
preventing heroin abuse.132 
3.  The Home 
To find another source of prescription medications, one need only look in the 
mirror, or rather, behind the mirror.  As mentioned above, prescriptions for 
controlled substances have increased dramatically in the last twenty years.133  This 
leads to an increased likelihood of unused prescriptions in the medicine cabinet.134  
These medications may be enticing to teenagers for “pharming,” who will in turn 
share the medications with friends who “pharmed” their own medicine cabinets. 135  
These medications are placed in a bowl called “trailmix,” which everyone shares at 
an event called a “pharm party.”136  The teens take pills from the “trailmix” 
randomly until they reach a sufficient high.137   But, not all pill combinations will 
make the taker feel high. Accordingly, teens tend to consume more pills, thereby 
increasing the risk that they may unwittingly overdose on the “trailmix”.138 
Pharm parties and similar problems are not exclusive to teenagers.  On March 2, 
2012, a first-grade student from Cleveland, Ohio brought a bottle of anti-depressant 
medications to school and passed them out.139  While there was no evidence that the 
child had bad intentions—as he may have thought that the medications were 
candy—eight students were still taken to the hospital.140  Thankfully, none of the 
children developed life-threatening complications.141  But, this story should serve as 
                                                            
 132 See Dissell, supra note 94. 
 133 NATIONAL INSTITUTE ON DRUG ABUSE, supra note 30. 
 134 Cf. Stan Donaldson, Prescription Drug Collection Nets More than 8,700 Pounds in 
Cleveland Area, THE PLAIN DEALER (Nov. 3, 2011 5:45 AM), http://blog.cleveland.com/metro 
/2011/11/prescription_drug_collection_n.html. While this article does not establish a causal 
relationship between number of prescriptions written and the amount of unused prescriptions 
in the home, the fact that over four tons of medications were collected at a local drug take-
back program supports the inference that there is a large amount of unused medications in 
peoples’ homes. 
 135 Donna Leinwand, Prescription Drugs Find Place in Teen Culture, USA TODAY (June 
13, 2006 7:40 PM), http://www.usatoday.com/news/health/2006-06-12-teens-pharm-
drugs_x.htm.  See also Kim-Katz & Anderson, supra note 34 (“Disturbingly, 41% of [teens] 
surveyed agreed that ‘using prescription drugs without a prescription is much safer to use than 
illegal drugs.’ This belief likely fuels the latest trend in drug abuse called “pharming,” the 
practice of adolescents raiding medicine cabinets in search of finding drugs for abuse.”) 
 136 See Leinwand, supra note 135. 
 137 Monica Kim Sham, Note, Down on the Pharm: The Juvenile Prescription Drug Abuse 
Epidemic and the Necessity of Holding Parents Criminally Liable for Making Drugs 
Accessible in their Homes, 27 J. CONTEMP. HEALTH L. & POL'Y 426, 436-37 (2011). 
 138 Id. 
 139 Kevin Freeman, Parents Shocked Over Elementary Overdose, FOX 8 CLEVELAND, 
(March 2, 2012, 10:35 PM), http://fox8.com/2012/03/02/elementary-school-students-rushed-
to-hospital-after-overdose/.   
 140 Id. 
 141 Id. 
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a warning of the dangers of prescription medications, and the ease to which they can 
be accessed in the home.  It would be difficult to fashion a law that would prevent a 
situation like this.  For this reason, primary responsibility lies with the parents to 
educate their children so that they understand that prescription medications are not 
candy, and can be dangerous when taken.   
As shown above, dangerous prescription medications are readily available to the 
public in many forms.  Specifically, controlled prescription drugs can be procured 
through pill mills, doctor shopping or in the home.142  Once the drugs are obtained, it 
is easy and even profitable to sell them on the street.143  Moreover, prescription drug 
abuse is dangerous to the health of an individual144 and places high costs on 
society.145  Although these drugs are dangerous and can be accessed easily, they still 
serve an important role in healthcare and it is necessary to find a solution capable of 
balancing competing illicit and legitimate medical interests. 
E.  Current State of Federal Law: Controlled Substances Act 
In 1970, President Richard Nixon signed into law the Controlled Substances Act 
(“CSA”).146 The CSA is a federal act that regulates the manufacture, possession, and 
distribution of certain medications.147  Among other things, the law creates five 
classifications (commonly known as “schedules”) to group various controlled 
substances.148  The drugs are placed in schedules based on their potential for abuse 
and whether they have any currently accepted medical use.149  Schedule I contains 
drugs that have the highest potential for abuse and no accepted medical use; 
examples include marijuana and heroin.150  Schedule II drugs have a high potential 
for abuse and severely limited medical purpose151—they include Adderall 
(amphetamine), Morphine, and Oxycontin (Oxycodone).152  Currently, physicians 
                                                            
 142 See generally supra Part II (discussing access to controlled prescription drugs). 
 143 See generally supra Part II.D.2 (discussing the financial incentives to sell prescription 
drugs on the street). 
 144 See generally supra Part II.A (discussing the health effects of abusing medications). 
 145 See generally supra Part II.B (discussing the costs prescription drug abuse places on 
society). 
 146 See Thirty Years of America’s Drug War, PBS, http://www.pbs.org/wgbh/pages/ 
frontline/shows/drugs/cron/ (last visited Oct. 28, 2012) (While the source does not directly 
state that President Nixon signed the bill into law, it can be inferred that he did because the 
law was enacted in 1970, during Richard Nixon’s presidency.). 
 147 See 21 U.S.C.S. § 801 (LexisNexis 2011) (discussing congressional findings regarding 
the possession, manufacture, and distribution of controlled substances). 
 148 21 U.S.C.S. § 802(6) (LexisNexis 2011). 
 149 21 U.S.C.S. § 812 (LexisNexis 2011). 
 150 21 U.S.C.S. § 812(c) (LexisNexis 2011). 
 151 21 U.S.C.S. § 812 (LexisNexis 2011). 
 152 21 U.S.C.S. § 812(c) (LexisNexis 2011); see Drugs and Medications – Adderall Oral, 
WEBMD, http://www.webmd.com/drugs/drug-63163Adderall+Oral.aspx?drugid=63163 
&drugname=Adderall+Oral (last visited Oct. 28, 2012) (the generic name for Adderall is 
amphetamine); see Drugs and Medications – OxyContin Oral, WEBMD, http://www 
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may only write prescriptions for drugs in Schedules II through V.153 Because the 
medical profession is highly regulated by the government, the Ohio legislature has 
the ability to enact a solution that more effectively curbs prescription drug abuse, 
such as the Oxycontin epidemic in Southern Ohio.154   
F.  Current State of Ohio Law vis-à-vis Prescription Reporting 
In 2006, the Ohio Pharmacy Board created the Ohio Automated Rx Reporting 
System (“OARRS”) in part to identify drug-seeking behaviors of patients.155  
OARRS is an online patient database that aggregates patient data into reports that 
can be accessed by physicians, pharmacists, and law enforcement.156  Similar patient 
databases are used in many states.157  The reports from these databases provide 
healthcare professionals and law enforcement agencies with valuable information 
such as a patient’s prescription history and physicians’ prescribing trends.158  The 
                                                            
.webmd.com/drugs/drug-2798OxyContin+Oral.aspx?drugid=2798&drugname=OxyContin+ 
Oral&source=1 (last visited Oct. 28, 2012) (the generic name for OxyContin is Oxycodone).   
 153 See 21 U.S.C.S. § 812(b)(1) (LexisNexis 2011). Schedule I drugs “[have] a high 
potential for abuse. . . [have] no currently accepted medical use in treatment, . . . [or] there is a 
lack of accepted safety for use of the drug or other substance under medical supervision.” Id. 
Thus, Schedule I drugs cannot be prescribed by a doctor under federal law. 
 154 See Tavernise, supra note 2. 
 155 What is OARRS?, OHIO AUTOMATED RX REPORTING SYSTEM, https://www.ohiopmp.gov 
/portal/Default.aspx (last visited Oct. 28, 2012). 
 156 Id. 
 157 See generally Donna Leinwand Leger, States Target Prescriptions by ‘Pill Mills,’ USA 
TODAY, http://www.usatoday.com/news/nation/story/2011-10-13/pill-mill-drug-
trafficking/50896242/1 (last updated Oct. 25, 2011 11:45 AM) (documenting prescription 
monitoring program databases by state).  States colored in dark blue have a fully operational 
prescription database.  Id. States colored in light blue have either proposed enabling 
legislation or enacted legislation providing for a prescription database, but no such database is 
active. Id. Missouri and Washington D.C., both colored white, have neither enacted nor 
proposed legislation to establish a prescription monitoring database. Id. 
 
 158 Id. 
120 JOURNAL OF LAW AND HEALTH [Vol. 26:103 
 
Ohio legislature granted the Ohio Pharmacy Board the authority to establish OARRS 
in 2005.159  The Ohio Pharmacy Board monitors the database to identify trends of 
overmedication, doctor shopping, and abuse.160  These reports can also include 
information regarding Ohio patients who had prescriptions filled in other states.161  
However, OARRS will only share prescription information with other states’ 
prescription monitoring programs if they meet Ohio’s statutory requirements and 
have signed a written agreement.162  As of the time this Note was written, OARRS 
can only interact with the prescription databases of nine other states.163 
Currently, “terminal distributors” of medications are required to submit 
information to OARRS regarding controlled medications that are dispensed to 
patients.164  Terminal distributors are defined as persons engaged in the sale of 
“dangerous drugs,” including pharmacies, hospitals, and nursing homes.165 The 
information submitted to OARRS includes the name of the patient, the prescriber, 
the date of the prescription, medication name, quantity, strength, and dosage.166  
With this information, prescribers, pharmacists, and law enforcement may request 
                                                            
 159 OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011) (“The state board of pharmacy may 
establish and maintain a drug database. The board shall use the drug database to monitor the 
misuse and diversion of controlled substances.”). 
 160 Id. 
 161 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, NAT’L ASS’N OF BOARDS OF PHARMACY (Aug. 19, 2011), http://www.nabp. 
net/news/ohio-deploys-nabp-pmp-interconnect-statewide-arizona-signs-on-to-participate/. 
 162 OHIO REV. CODE ANN. § 4729.80(A)(11) (LexisNexis 2011) (“On receipt of a request 
from . . . another state's prescription monitoring program, the board may provide to the 
requestor information from [OARRS], but only if there is a written agreement under which the 
information is to be used and disseminated according to the laws of this state.”); see also 
Connecting to PMP InterConnect, NAT’L ASS’N OF BOARDS OF PHARMACY, http://www.nabp 
.net/programs/pmp-interconnect/nabp-pmp-interconnect/connecting-to-pmp-interconnect/ (last 
visited Oct. 28, 2012). These written agreements are known as a “memorandum of 
understanding.” Id. The National Association of Boards of Pharmacy has a model 
memorandum drafted which lays out each state’s rights, responsibilities, and privileges with 
respect to maintaining the interstate pharmacy database connection. See id. 
 163 Ohio’s OARRS can interact with the prescription monitoring programs of nine states: 
Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota, South Carolina, Virginia, 
and West Virginia.  Noticeably missing from this list are Michigan, Kentucky, and 
Pennsylvania—three states that share a border with Ohio. See Ohio Deploys NABP PMP 
InterConnect Statewide, Arizona Signs On to Participate, supra note 161. 
 164 OHIO REV. CODE ANN. § 4729.77 (LexisNexis 2011) (“[E]ach pharmacy licensed as a 
terminal distributor of dangerous drugs . . . shall submit to the board the following 
prescription information: [prescription information such as patient name, doctor, drug 
dispensed, quantity, etc.]”).  
 165 OHIO REV. CODE ANN. § 4729.01(Q) (LexisNexis 2011). 
 166 OHIO REV. CODE ANN. §4729.77 (LexisNexis 2011). 
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reports regarding medication dispensed to patients in order to better serve the health 
of the patient and to protect the public at large.167 
In response to the growing prescription abuse epidemic, the Ohio General 
Assembly enacted House Bill 93 in 2011.168  This Bill includes prescribers who 
dispense drugs (one of the hallmarks of a pill mill) in the definition of “terminal 
distributors.”169  Thus, all prescribers who fall into the category of distributors 
(including dentists, physician’s assistants, and nurse practitioners) must now report 
drug dispenses to OARRS.170  The goal was to make it easier for law enforcement 
agencies to identify pill mills without adversely affecting legitimate pain clinics that 
properly prescribe controlled medications.171  Specifically, agencies look for trends 
of physicians prescribing and dispensing high volumes of narcotic medications paid 
for by the patient without any assistance from insurance companies.172 
In addition to the changes promulgated by House Bill 93, the Ohio Medical 
Board enacted Rule 4731-11-11 in 2011 as part of an effort to go above and beyond 
affecting only pain clinics, but to also affect all physicians who prescribe controlled 
medications.173  Rule 4731-11-11 requires physicians to review OARRS reports on 
patients if “the physician is aware of a patient suffering from addiction, drug abuse, 
or engaging in diversion of drugs.”174  Furthermore, physicians must review an 
OARRS report on their patient at the beginning of treatment and once annually 
thereafter if the patient is being treated for more than twelve weeks.175  These 
                                                            
 167 OHIO REV. CODE ANN. § 4729.80 (LexisNexis 2011). Pharmacists and prescribers may 
only request reports on patients that they are currently treating. Id. Law enforcement may only 
request reports in conjunction with an investigation of a drug offense. Id. 
 168 See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at http://www. 
legislature.state.oh.us/bills.cfm?ID=129_HB_93; Gov. Kasich Signs House Bill 93, OHIO 
NEWS NETWORK (May 20, 2011), http://www.onntv.com/content/stories/2011/05/21/story-pill-
mills.html (“Gov. John Kasich . . . signed House Bill 93 into law which will now help 
legislation that fights Ohio’s prescription drug abuse epidemic.”). 
 169 See H.B. 93.  
 170 Id.; see also OHIO ADMIN. CODE 4715-6-01 (LexisNexis 2011) (requiring dentists to 
report controlled medication dispenses to OARRS, and to review reports on patients in certain 
situations); see also OHIO ADMIN. CODE 4723-9-12 (LexisNexis 2011) (requiring nurse 
practitioners to report controlled medication dispenses to OARRS, and to review reports on 
patients in certain situations).  
 171 Zimmer, supra note 20. 
 172 See generally supra Part II.B.1 (describing the characterization of pill mills). 
 173 House Bill 93 – New Law to Combat Prescription Drug Abuse, GRAND ROUNDS – YOUR 
REPORT FROM THE STATE MEDICAL BOARD OF OHIO (May 2011), available at http://www.med. 
ohio.gov/pdf/Newsletters/Spring11_Special_HB93.pdf. 
 174 OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011). 
 175 See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011) (“A physician . . . shall, at a 
minimum, document receipt and assessment of an OARRS report . . . [o]nce the physician has 
reason to believe that the treatment will be required on a protracted basis; and [a]t least once 
annually, therafter.”);  See OHIO ADMIN. CODE 4731-11-11(A)(4) (Lexis Nexis 2011) (defining 
“protracted basis” as “a period in excess of twelve continuous weeks.”). 
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measures seek to provide physicians with as much information about their patient’s 
medical history as possible before they prescribe a potentially dangerous drug.176   
While Rule 4731-11-11 is more stringent than House Bill 93, neither law goes far 
enough to prevent prescription drug abuse by patients.  Ohio may have created 
OARRS to identify trends of prescription abuse, yet not all physicians are required to 
run reports from OARRS on controlled substances dispensed to the patient.177  Thus, 
physicians, law enforcement agencies, and pharmacists are pulling reports from an 
incomplete database.  Given the risks of prescription abuse, and the shortcomings of 
the current system, a solution that addresses each of these problems is needed.   
III.  ARGUMENT 
Ohio has made great strides to combat prescription drug abuse.178  In spite of 
legislative efforts, new laws such as House Bill 93 and Medical Rule 4731-11-11 
have shortcomings because they react to the problem of pill mills, instead of 
combating prescription abuse generally.179  In addition to these recent changes, the 
Ohio legislature should mandate reporting for all controlled medication, make 
OARRS interface with the prescription databases of other states, better promote 
prescription return programs, and strengthen its laws regarding doctor shopping.  By 
taking these additional measures, Ohio will more effectively prevent the problem of 
prescription drug abuse. 
A.  Core Competencies of House Bill 93 and Medical Rule 4731-11-11 
House Bill 93 and Medical Rule 4731-11-11 are a step in the right direction to 
curb prescription abuse for two reasons.  First, House Bill 93 makes it very difficult 
to operate pill mills, while simultaneously making it easier for healthcare providers 
to access OARRS.180  Second, Medical Rule 4731-11-11 mandates OARRS reporting 
in some situations, which provides physicians with more information on medications 
their patients are already taking.181 
1.  House Bill 93 Makes It Difficult to Operate Pill Mills in Ohio 
House Bill 93 has been effective in closing Ohio’s pill mills.182  In fact, many of 
the pill mills in Portsmouth shut down before House Bill 93 took effect.183  These pill 
                                                            
 176 See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173. 
 177 See generally supra Part II.F (describing who must report to OARRS and what 
information must be reported). 
 178 See generally supra Part II.F (describing laws adopted by Ohio to combat prescription 
drug abuse). 
 179 See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173. 
 180 See House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173. 
 181 See OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011).  
 182 Noah Adams, A County Takes Down Prescription Pill Mills, NPR (June 19, 2011), 
http://www.npr.org/2011/06/19/137284148/a-county-triumphs-over-prescription-pill-mills 
(noting that at the time the article was written, all pill mills in Portsmouth had shut down); see 
also Alan Johnson, Prayers Answered: Scioto County’s Last ‘Pill Mill’ Shut, COLUMBUS 
DISPATCH, http://www.dispatch.com/content/stories/local/2011/12/21/prayers-answered-
sciotos-last-pillmillshut.html (Dec. 21, 2011 5:52 AM) (noting that the last pill mill in Scioto 
county shut down at the end of 2011). 
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mills shut down in part because they did not want to comply with H.B. 93 and Rule 
4731-11-11.184  Under H.B. 93, prescribers who actually dispense controlled 
medications, rather than merely prescribing medications, must report to OARRS the 
controlled medications they dispense.185  This allows Ohio’s Pharmacy Board to 
identify pill mills operating under the guise of pain management clinics.186  
Additionally, Medical Rule 4731-11-11 requires all pain management clinics to be 
licensed to continue operation.187  This licensing requirement allows law 
enforcement agencies to monitor pain management clinics without adversely 
affecting the clinics that properly prescribe controlled substances and explore 
alternative treatment options.188  Finally, under H.B. 93, only physicians may be 
licensed to run these clinics.189  This keeps laypersons—who may have ambitions 
that contradict a physician’s Hippocratic Oath—out of the practice of medicine. 
2.  The Recent Changes Also Enable Easier Access to OARRS 
House Bill 93 increases healthcare providers’ access to information.  All support 
staff within a physician’s office can now apply for an account to run OARRS reports 
on patients.190  Previously, only prescribers were able to apply for these accounts.191  
This change allows physicians to delegate the task of running reports to support 
staff.192 
                                                            
 183 Adams, supra note 182. 
 184 Id. 
 185 OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011). (“If [Ohio] . . . maintains a 
drug database . . . , each licensed health professional  . . . who personally furnishes a 
controlled substance or other dangerous drug . . . to a patient in this state shall submit to the 
board the following information: [information about the prescription, including patient name, 
doctor name, drug name, dosage, etc.]”); see also H.B. 93, 129th Gen. Assemb., Reg. Sess. 
(Oh. 2011), available at http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93 
(summarizing the changes brought by House Bill 93). 
 186 See generally OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011) (providing that 
persons who furnish a drug to a patient must report this act to a database controlled by the 
Ohio Pharmacy Board). 
 187 House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173. A pain 
management clinic is defined as a place where “[t]he primary component of practice is 
treatment of pain or chronic pain; [and t]he majority of patients of the prescribers at the 
facility are provided treatment for pain or chronic pain that includes the use of controlled 
substances, tramadol, carisoprodol, or other drugs specified in rules adopted under this 
section.” OHIO REV. CODE ANN. § 4731.054(A)(5)(a)(i-ii) (LexisNexis 2011).  
 188  H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at 
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93. 
 189 House Bill 93 – New Law to Combat Prescription Drug Abuse, supra note 173.  
 190 See OHIO REV. CODE ANN. § 4729.80(a)(5) (LexisNexis 2011) (providing agents of the 
prescriber the ability to request reports from OARRS).   
 191 See generally H.B. 93. Prior to House Bill 93, section 4729.80(a)(5) gave only 
prescribers and pharmacists the ability to access the database. Id. 
 192  See OHIO REV. CODE ANN. § 4729.80(a)(5) (LexisNexis 2011).  
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Medical Rule 4731-11-11 also works in tandem with House Bill 93 by requiring 
pain management physicians to run reports on patients at the inception of treatment 
and once annually thereafter.193 The rule obligates physicians to monitor their 
patients and ensure that they are not “shopping” elsewhere to get medication.194  
Also, this rule establishes a duty to run a report if a physician suspects a patient of 
abusing medication.195  Rule 4731-11-11 places more duties on a physician to ensure 
patients do not abuse medication.196  
B.  Shortcomings of H.B. 93 and Rule 4731-11-11 
The enactment of House Bill 93 and Rule 4731-11-11 are moves in the right 
direction to combat prescription abuse in Ohio.  There are problems with these 
recent changes, however.  First, there are technical issues with these laws.  Second, 
they react to the problem of pill mills197 but do not adequately address the core of the 
prescription abuse problem. 
1.  Technical Issues with Ohio’s Current Law 
Despite the efficacy of H.B. 93 in eliminating pill mills,198 in general the law 
does not curb prescription drug abuse.199  Doctor-shopping patients can still visit a 
pain clinic, and “explore” alternative treatments, only to find that it “was not 
effective” and potentially receive the prescription for the drug of their choice.200  
Thus, a patient who never has a real medical need for a medication is free to abuse it, 
or sell it on the street.201 
Currently, Ohio does not have an adequate “doctor shopping statute.”202  
Although Ohio criminalizes procuring medication through deceit (i.e. doctor 
shopping) under section 2925.22, case law has only found “deceit” where a patient 
                                                            
 193 See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011). 
 194 Id.  
 195 See OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011) (setting forth a list of “red 
flags” that should trigger suspicions of abuse, such as early refills, requesting brand name 
drugs instead of generic, patient appearing to appointment intoxicated, etc.). 
 196 OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011); H.B. 93, 129th Gen. Assemb., 
Reg. Sess. (Oh. 2011), available at 
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93. 
 197 See Zimmer, supra note 20.   
 198 See Adams, supra note 182 (explaining that at the time of the writing of the article, all 
pill mills in Portsmouth had shut down). 
 199 H.B. 93. 
 200 See H.B. 93. Noticeably absent from the bill is any provision relating to doctor 
shopping. See id. 
 201 See generally supra Part II.C.2 (describing the street prices of prescription drugs and the 
temptation of selling them on the street).  
 202 OHIO REV. CODE ANN. § 2925.22(A) (LexisNexis 2011) (“[n]o person, by deception, 
shall procure . . . a dangerous drug . . .”). 
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forged a prescription or visited multiple physicians to procure medication.203  Based 
on case law, section 2925.22 would be ineffective to prevent “deceit” where a drug-
seeking patient went to a pain clinic, explored alternate pain management 
techniques, but still dishonestly complained of pain.204  Moreover, even if the law 
successfully prosecuted doctor shoppers, it could only do so after the patients have 
illicitly procured dangerous medications.  
However, Ohio cannot easily tighten the grip of section 2925.22.  If the 
legislature strengthened this law, or put the “burden of proof of pain” on the patient, 
patients with real health conditions treatable only by medication could 
unintentionally be caught in the web.205  Patients who have a hard time managing 
health problems may be justified in using painkillers.206  Further, it would still be 
very difficult to find deceit in the case of an interstate doctor shopper, as OARRS 
can only interact with the prescription databases from nine other states.207   The 
solution to curbing prescription abuse is not to increase the scope of section 2925.22.   
Similarly, Rule 4311-11-11 has structural problems.  Currently, physicians must 
run reports on their patients at the inception of treatment if they believe treatment 
will be necessary for twelve weeks or longer, and once annually thereafter.208  
Physicians must also review OARRS reports on their patient when they suspect 
prescription abuse.209  One year is a long time to wait to run these reports if abuse is 
not suspected.  Requiring a physician to run these reports more often may prevent an 
abuse problem, or catch the problem in its early stages.   
House Bill 93 and Rule 4731-11-11 create a loophole in the law when they work 
together.210  First, House Bill 93 does not require the physician to report information 
in OARRS if a physician does not dispense medication to a patient.211  Additionally, 
                                                            
 203 Cf. State v. O'Connell, 2011-Ohio-652, 655 (Ohio Ct. App. 2011); State v. Hartney, 
2010-Ohio-4331, 4332-33 (Ohio Ct. App. 2010); State v. Newland, 2009-Ohio-1340, 1341-43 
(Ohio Ct. App. 2009). In these cases, deceit could be proven where the defendant visited 
multiple doctors to obtain prescriptions of pain medications, and these doctors did not know 
about the existence of the other doctors.  No case can be found on point where deceit was 
alleged when a patient had only one doctor. 
 204 OHIO REV. CODE ANN. § 2925.22(A) (LexisNexis 2011). 
 205 See Lowes, supra note 105. Although discussing prescription abuse in the context of 
Medicare fraud, the same tension exists here. The author notes in the article that if Medicare 
regulations were tightened to prevent medication abuse, patients with legitimate and 
complicated problems who see four or five specialists to treat their condition could be caught 
in the web. Id. 
 206 Id.  
 207 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161 (explaining that OARRS can interact with the prescription 
monitoring programs in Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota, 
South Carolina, Virginia, and West Virginia). 
 208 See OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011). 
 209 OHIO ADMIN. CODE 4731-11-11(B) (Lexis Nexis 2011). 
 210 See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at 
http://www.legislature.state.oh.us/bills.cfm?ID=129_HB_93l; OHIO ADMIN. CODE 4731-11-
11(C) (Lexis Nexis 2011). 
 211 OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011).  
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Rule 4731-11-11 only requires physicians to review an OARRS report at the 
inception of a twelve-week or longer treatment.212  Therefore, if a patient visits 
multiple physicians on a short-term basis to receive controlled medications, the 
patient’s drug-seeking behaviors may go undetected.  A patient’s drug-seeking 
behavior may only be uncovered when a patient fills a prescription at an Ohio 
pharmacy, because once a prescription is filled, it will be reported to OARRS.213  
However, OARRS cannot report on this information, and, therefore, OARRS users 
are running reports on an incomplete database if a patient fills a prescription in 
Kentucky, or any of the 39 other states incompatible with OARRS.214  Thus, a 
patient’s healthcare provider, as well as Ohio’s law enforcement agencies, may be 
oblivious to all medications a patient receives.  This is especially troubling when 
Scioto County, Ohio—a county with a high rate of opiate consumption—215 borders 
with Kentucky, which has similar prescription abuse problems.216  Thus, the Ohio 
legislature should fill this statutory hole, or promote pharmacy database 
communications between Ohio and other states in order to effectively combat 
prescription abuse.  
2.  Reactive 
Ohio’s recent changes are also reactive to the epidemic of pill mills.  While 
House Bill 93 removes one source of prescriptions in Ohio, there is more that could 
have been done.  Neither House Bill 93 nor Medical Rule 4731-11-11 identify 
patients who receive a modest supply of drugs from only one physician and either 
abuse the medicine or sell it on the street.217  Conversely, these laws are partially 
successful in curbing doctor shopping because they require prescribers to report 
                                                            
 212 See OHIO ADMIN. CODE 4731-11-11(C) (LexisNexis 2011). 
 213 OHIO REV. CODE ANN. § 4729.77 (LexisNexis 2011) (setting forth requirement that 
pharmacies report prescription information to OARRS). 
 214 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161 (indicating that OARRS can interact with the prescription 
monitoring programs in Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota, 
South Carolina, Virginia, and West Virginia).  But see Leger, supra note 157 (mentioning that 
OARRS can interact with Kentucky’s KASPER). Given this discrepancy, and the 
memorandum of understanding between Kentucky and Ohio, it appears the Kentucky and 
Ohio have agreed in theory to share prescription information, but have not yet performed the 
necessary technical work to connect the databases. 
 215 See generally Ohio’s Opiate Epidemic: User Profiles, supra note 86 (table displaying 
prescription opiate consumption per capita in each of Ohio’s counties). 
 216 See generally Politicians, Physicians Should Lead Fight Against Ky. Pill Mills, 
KENTUCKY.COM (Nov. 15, 2011), http://www.kentucky.com/2011/11/15/1960000/politicians-
physicians-should.html (describing generally the problems Kentucky faces with pill mills); cf. 
Tavernise, supra note 2 (describing generally the havoc wrought in Southern Ohio by pill 
mills). 
 217  See H.B. 93, 129th Gen. Assemb., Reg. Sess. (Oh. 2011), available at http://www. 
legislature.state.oh.us/bills.cfm?ID=129_HB_93l; OHIO ADMIN. CODE 4731-11-11(C) 
(LexisNexis 2011). 
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controlled medications dispensed to OARRS in all situations, but require reports to 
be run only in some situations.218   
Rule 4731-11-11 is more effective in combating doctor shopping opposed to 
H.B. 93. However, the rule still falls far short to tackle the problem head-on.  For 
example, Rule 4731-11-11 requires physicians to view OARRS reports on their 
patients when they suspect their patients of abusing medications or suspect that the 
patient will be treated with a controlled substance for more than twelve weeks.219  
These rules are easily circumvented.  First, the requirement that physicians view 
reports on their patients where abuse is suspected is based partially on the 
physician’s subjective belief.220  The physician could easily circumvent the rule 
simply by saying, “I did not think my patient was abusing medications.”221  Second, 
an ill-intentioned physician may agree to only treat a patient with controlled 
medications for less than twelve weeks.222 
Ohio’s current statutory scheme also does not effectively prevent the cycle of 
abuse.  While H.B. 93 removes pill mills as a source of prescriptions for patients, it 
does not attack the root problem, namely, stopping patients from abusing 
medications.  Further, physicians may prescribe a controlled medication, such as 
Oxycontin, to their patient in good faith, when in reality that patient was simply 
shopping for medication.  If this physician failed to investigate a patient’s medical 
history and this patient was doctor shopping, the physician could be liable for failing 
to investigate the patient’s medical history.223  This illustrates that “[t]he problem 
with the current legislation is that [Ohio’s] criminal sanctions represent reactive 
                                                            
 218 “[E]ach licensed health professional . . . who personally furnishes a controlled substance 
or other dangerous drug . . . to a patient in this state shall submit to the board the following 
information . . . ” OHIO REV. CODE ANN. § 4729.79(A) (LexisNexis 2011); OHIO ADMIN. CODE 
4731-11-11(B) (LexisNexis 2011) (delineating the situations that require prescribers to view 
OARRS reports on their patients). 
 219 See OHIO ADMIN. CODE 4731-11-11(B) (LexisNexis 2011) (“If a physician believes or 
has reason to believe that a patient may be abusing or diverting drugs, the physician shall use 
sound clinical judgment in determining whether or not the reported drug should be prescribed 
or personally furnished to the patient under the circumstances.”); OHIO ADMIN. CODE 4731-11-
11(C) (LexisNexis 2011) (“A physician prescribing . . . reported drugs to treat a patient on a 
protracted basis shall, at a minimum, document receipt and assessment of an OARRS report . . 
. [a]t least once annually . . .”).  Further, a “protracted basis” is defined as “a period in excess 
of twelve continuous weeks.” OHIO ADMIN. CODE 4731-11-11(A)(4) (LexisNexis 2011). 
 220 “If a physician believes or has reason to believe that a patient may be abusing or 
diverting drugs . . . the physician shall access OARRS.”  OHIO ADMIN. CODE 4731-11-
11(B)(1) (LexisNexis 2011). 
 221 At the time this Note was written, Rule 4731-11-11 had just taken effect and therefore 
had not yet been interpreted by Ohio case law. 
 222 OHIO ADMIN. CODE 4731-11-11(C) (Lexis Nexis 2011) (requiring that doctors must 
review patient reports if treating for twelve weeks).  Thus, if a doctor treats a patient for only 
eleven weeks, there is no duty to run an OARRS report on a patient. 
 223 OHIO ADMIN. CODE 4731-11-11(B)(1) (Lexis Nexis 2011). A physician must review an 
OARRS report if he “believes or has reason to believe that a patient may be abusing or 
diverting drugs.” Id. Because the regulation is so new, there is no case law yet elaborating or 
providing examples of when the physician “had reason to believe” her patient was abusing or 
diverting prescription medications. 
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remedies because penalties can only be imposed after a finding of unlawful 
distribution . . .”224 While sanctions for breaking the law may convince prescribers 
and patients to follow it, “a reactive remedy cannot retroactively repair any damage 
which the unlawfully prescribing physician may have caused in the way of physical 
and psychological dependence in addicted victims.”225  Thus, Ohio needs a solution 
that prevents prescription drug abuse before the damage to the patient is done.   
House Bill 93 does not prevent injury to patients.  As noted above, it requires 
prescribers who furnish drugs to patients to report this activity to OARRS.226  While 
the Ohio Pharmacy Board will monitor this database for trends of overmedication, 
doctor shopping and abuse, prescribers do not need to monitor the database in many 
situations.227  Prescribers, who are in the best position to identify signs of patient 
drug abuse, are not required in all situations to review an OARRS report on their 
patient, which will delineate all controlled medications received by the patient in the 
last two years.228  And before a trend is identified by law enforcement an ill-
intentioned patient could have either amassed a large quantity of drugs to sell on the 
street, or harmed themselves by taking these drugs.229  Regardless, the damage is 
already done before the pharmacy board can take action.  Thus, Ohio should instead 
adopt a solution that can stop the problem of medication abuse before another 
situation similar to the “Portsmouth” problem happens elsewhere in Ohio. 
C.  Proposed Solution 
As shown above, prescription drug abuse is a complex problem in Ohio that has 
life altering consequences, is extremely costly, and is a problem not adequately 
addressed by Ohio’s current legislation.230  Further, Ohio’s law addressing 
prescription drug abuse is confusing regarding who has to review reports on their 
patients and when.231 Thus, more needs to be done to help prevent abuse. The first 
step would be to require mandatory OARRS monitoring for all controlled 
                                                            
 224 David L. Robinson, Bridging the Gaps: Improved Legislation to Prohibit the Abuse of 
Prescription Drugs in Virginia, 9 APPALACHIAN J. L. 281, 282 (2010). Although this law 
review article discusses Virginia’s challenges with prescription abuse, Ohio has similar 
challenges. 
 225 Id. 
 226 OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011). 
 227 OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011); OHIO ADMIN. CODE 4731-11-
11(B) (LexisNexis 2011). 
 228 OHIO REV. CODE ANN. §§ 4729.77–.79 (LexisNexis 2011).  
 229 See generally supra Part II.C.2 (describing the danger and temptation of selling 
prescriptions on the street).  See also Lowes, supra note 105 (discussing case studies of 
patients amassing large quantities of drugs). 
 230 See supra Part III.B.1–2. 
 231 Cf. OHIO ADMIN. CODE 4731-11-11(C) (LexisNexis 2011) (requiring doctors to review 
patient reports if treating for more than twelve weeks); OHIO ADMIN. CODE 4731-11-11(B) 
(LexisNexis 2011) (requiring doctors to review OARRS patient reports if they suspect abuse); 
OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011) (requiring prescribers to submit reports to 
OARRS if they physically dispense medications to a patient, with no requirement to run a 
report).   
2013] PHARMAGEDDON: A STATUTORY SOLUTION 129 
 
medications. This includes running reports on patients before medication is 
prescribed, and reporting to OARRS the controlled medications that were dispensed. 
The second step would require OARRS to interact with the prescription monitoring 
programs of other states. The third step is to better promote the current pharmacy 
take back programs. The final step would be to create a stronger anti-doctor 
shopping statute. While these suggestions are not a panacea to end Ohio’s 
prescription abuse epidemic, they more effectively remove the fuel to the fire of 
prescription abuse, instead of simply treating the symptoms of abuse. 
1.  Mandatory OARRS Monitoring 
Given the nature of Ohio’s drug abuse problem, the Ohio legislature should 
require all physicians to run OARRS reports on their patients before writing 
prescriptions for controlled medication, and report to OARRS controlled 
medications prescribed to patients. As previously mentioned, H.B. 93 allows hospital 
support staff to sign up for OARRS,232 which would decrease the administrative 
burden on physicians.233 The Ohio State Board of Pharmacy already offers access to 
OARRS to practitioners and pharmacists at no cost.234 The information from these 
free reports would allow physicians to quickly and efficiently identify the drug-
seeking behaviors of their patients.235 Physicians would then have the necessary tools 
to make prescribing decisions in the best interests of their patient’s health.   
In order to establish these requirements, Ohio first needs to amend O.R.C. 
Sections 4729.79 and 4729.80(A)(5). Section 4729.79 currently reads:  
(A) If the state board of pharmacy establishes and maintains a drug 
database . . . , each licensed health professional authorized to prescribe 
drugs, other than a veterinarian, who personally furnishes a controlled 
substance or other dangerous drug the board includes in the database 
pursuant to rules adopted under section 4729.84 of the Revised Code to a 
patient in this state shall submit to the board the following information: 
(1) Prescriber identification; 
(2) Patient identification; 
(3) Date drug was furnished by the prescriber; 
(4) Indication of whether the drug furnished is new or a refill; 
(5) Name, strength, and national drug code of drug furnished; 
(6) Quantity of drug furnished; 
(7) Number of days’ supply of drug furnished; 
                                                            
 232 See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the 
prescriber the ability to request reports from OARRS).   
 233 See generally supra Part III.A (discussing the positive changes that House Bill 93 and 
Medical Rule 4731-11-11 bring). 
 234 William T. Winsley & Donna E. Droz, Ohio’s Dangerous Drug Database Past, 
Present, and Future: House Bill 93 Report, OHIO STATE BOARD OF PHARMACY AUTOMATED 
(November 21, 2011), https://www.ohiopmp.gov/portal/docs.aspx (follow “Legislative Report 
for HB 93” hyperlink). 
 235 See Tribble, supra note 113 (“If doctors were required to check the database, they 
would spot patients who were pill shopping, going to multiple pain clinics and emergency 
rooms to obtain prescriptions or samples.”). 
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(8) Source of payment for the drug furnished.236 
The Ohio legislature should amend Section 4729.79(A) to read (changes in 
italics): 
(A) If the state board of pharmacy establishes and maintains a drug 
database  . . . , each licensed health professional authorized to prescribe 
drugs, other than a veterinarian, who personally furnishes or prescribes a 
controlled substance or other dangerous drug the board includes in the 
database pursuant to rules adopted under section 4729.84 of the Revised 
Code to a patient in this state shall submit to the board the following 
information: 
(1) Prescriber identification; 
(2) Patient identification; 
(3) Date drug was furnished or prescribed by the prescriber; 
(4) Indication of whether the drug furnished or prescribed is new or a 
refill; 
(5) Name, strength, and national drug code of drug furnished, and name 
and strength of drug prescribed; 
(6) Quantity of drug furnished or prescribed; 
(7) Number of days’ supply of drug furnished or prescribed; 
(8) Source of payment for the drug furnished. 
Essentially, Section 4729.79(A) would be amended to include “or prescribe” 
anywhere the word “furnished” appears. This would provide that all controlled drugs 
prescribed are reported to OARRS. Thus, if a patient fills their prescription out of 
state, OARRS will still have information that a patient may have received the drug.  
While reporting controlled medications prescribed to OARRS may seem daunting at 
first, many physicians’ offices already store records electronically, and have even 
begun to send prescriptions via email.237 Some states similarly require prescribers to 
send their prescriptions electronically to pharmacies, which has the added benefit of 
ensuring accuracy and tracking whether a prescription was filled.238 If Ohio enacted 
a similar requirement, prescribers would need to submit the same information to the 
pharmacy board. 
However, requiring that prescribers report medications prescribed is not enough.  
The Ohio legislature needs to also require that all physicians monitor reports on their 
patients before prescribing or dispensing a controlled medication.  As a result, 
physicians will be able to see what controlled medications their patient is taking, as 
well as prescriptions they may have received from an Ohio physician, but were filled 
                                                            
 236 OHIO REV. CODE ANN. § 4729.79 (LexisNexis 2011). 
 237 See Associated Press, New York Lawmakers OK Electronic Drug Prescriptions Bill, 
SYRACUSE.COM (June 11, 2012, 7:20 PM), http://www.syracuse.com/news/index.ssf/ 
2012/06/new_york_lawmakers_ok_electron.html (“[D]octors already are moving toward 
writing prescriptions electronically. . .”). 
 238 See id. (discussing New York’s requirement that physicians must electronically submit 
prescriptions to pharmacies within three years).  
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in another state.239  To make this a requirement, the Ohio Legislature needs to amend 
Section 4729.80(A)(5). This section currently reads:  
(A) If the state board of pharmacy establishes and maintains a drug 
database . . . the board is authorized or required to provide information 
from the database . . . : 
(5) On receipt of a request from a prescriber or the prescriber’s agent 
registered with the board, the board may provide to the prescriber 
information from the database relating to a current patient of the 
prescriber, if the prescriber certifies in a form specified by the board that 
it is for the purpose of providing medical treatment to the patient who is 
the subject of the request.240 
The Ohio legislature should amend Section 4729.80(A)(5) to read (changes in 
italics): 
(A) If the state board of pharmacy establishes and maintains a drug 
database . . . the board is authorized or required to provide information 
from the database . . . : 
(5) On receipt of a request from a prescriber or the prescriber’s agent 
registered with the board, the board must provide to the prescriber 
information from the database relating to a current patient of the 
prescriber, if the prescriber certifies in a form specified by the board that 
it is for the purpose of providing medical treatment to the patient who is 
the subject of the request. Such request shall be made by the prescriber or 
the prescriber’s agent registered with the board if the doctor is currently 
treating the patient with a controlled drug as defined by the Controlled 
Substances Act (21 U.S.C.S. § 812) or a dangerous drug. 
Under the proposed Section 4729.80(A)(5), prescribers who treat their patients 
with controlled medications would now be required to monitor OARRS reports on 
their patients. The changes to this section include replacing “may” with “must.” 
Specifically, the pharmacy board was previously not required to provide OARRS 
reports to requesting physicians.241 Still, some practitioners are concerned that 
monitoring OARRS reports on patients can be time-consuming.242 But, the Ohio 
State Board of Pharmacy has reported that 99.5% of all report requests in 2011 were 
processed in less than three seconds, which directly contradicts this criticism.243 
Under this proposal, medical support staff can reliably request OARRS reports on all 
                                                            
 239 See infra Part III.C.2 (discussing the challenges of ascertaining medications a patient 
received in another state, and a solution to that challenge). 
 240 OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011).  
 241 See id. (“On receipt of a request from a prescriber or the prescriber’s agent registered 
with the board, the board may provide to the prescriber . . . .” (emphasis added)). 
 242 Cf. Zimmer, supra note 20 (“[D]octors have issues with the cumulative time 
commitment of system checks. Others have criticized it for the lag time between when a 
prescription is filled and when that activity actually appears in the database.”); Tribble, supra 
note 113 (arguing that OARRS reporting “would hit doctors at a time when they are seeing 
more patients and implementing their own electronic medical records.”). 
 243 See Winsley & Droz, supra note 234. 
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patients the physician will consult with at the beginning of the day. Thus, the 
physician will have OARRS information on all of their patients before patients 
arrive. 
The proposed amendment to Section 4729.80(A)(5) also includes language from 
House Bill 93.  Specifically, it notes that either the physician, or the physician’s 
support staff can make reports.244  In addition, this proposed change incorporates 
terms of art from the definitions of Section 4729(F). Specifically, “Dangerous Drug” 
is defined as: 
(F) “Dangerous drug” means any of the following: 
(1) Any drug to which either of the following applies: 
(a) Under the “Federal Food, Drug, and Cosmetic Act,” 52 Stat. 1040 
(1938), 21 U.S.C.A. 301, as amended, the drug is required to bear a label 
containing the legend “Caution: Federal law prohibits dispensing without 
prescription” or “Caution: Federal law restricts this drug to use by or on 
the order of a licensed veterinarian” or any similar restrictive statement, 
or the drug may be dispensed only upon a prescription; 
(b) Under Chapter 3715. or 3719. of the Revised Code, the drug may be 
dispensed only upon a prescription. 
(2) Any drug that contains a schedule V controlled substance and that is 
exempt from Chapter 3719. of the Revised Code or to which that chapter 
does not apply; 
(3) Any drug intended for administration by injection into the human 
body other than through a natural orifice of the human body.245 
Under the proposed change, the use of the term “controlled drug” captures any 
drug that the FDA has classified as “dangerous.”246 
The mandatory monitoring requirement could also be codified within the Ohio 
Administrative Code.  In order to establish these requirements, Ohio can amend 
Medical Rule 4731-11-11,247 Dental Rule 4715-6-01,248 and Nursing Rule 4723-9-
12.249  These rules propagated by the Ohio Medical, Dental, and Nursing Boards 
delineate situations in which prescribers should review OARRS reports on their 
patients before prescribing controlled medications.250 Instead, the rule should require 
                                                            
 244 See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the 
prescriber the ability to request reports from OARRS); see supra Part III (describing positive 
changes of H.B. 93, one of which being access to OARRS by medical support staff). 
 245 OHIO REV. CODE ANN. § 4729.01(F) (LexisNexis 2011). 
 246 21 U.S.C.S. § 812(c) (LexisNexis 2011) (listing all drugs the FDA has listed as 
“controlled”). 
 247 OHIO ADMIN. CODE 4731-11-11 (LexisNexis 2011). 
 248 OHIO ADMIN. CODE 4715-6-01 (LexisNexis 2011). 
 249 OHIO ADMIN. CODE 4723-9-12 (LexisNexis 2011). 
 250 See e.g. OHIO ADMIN. CODE 4731-11-11(B)(1) (LexisNexis 2011) (requiring physicians 
to review an OARRS report on patients in certain situations before prescribing a controlled 
drug); OHIO ADMIN. CODE 4715-6-01(B)(1) (LexisNexis 2011) (requiring dentists to review an 
OARRS report on patients in certain situations before prescribing a controlled drug); OHIO 
ADMIN. CODE 4723-9-12(B)(1) (LexisNexis 2011) (requiring nurse practitioners to review an 
OARRS report on patients in certain situations before prescribing a controlled drug). 
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prescribers to review OARRS reports on their patients in all situations before 
prescribing a controlled drug.   
Mandatory controlled prescription monitoring is not a novel idea.  New York’s 
legislative branch recently passed a similar requirement, known as The Internet 
System for Tracking Over-Prescribing Act (“I-STOP”).251  I-STOP has not yet been 
signed into law in New York, although it did pass both the state Senate and House of 
Representatives, and Governor Cuomo supported the effort to pass I-STOP.252  
While the initiative is obviously too new to discern the ramifications of I-STOP, it 
will likely curb prescription abuse because physicians will now review a patient’s 
controlled medication history, before prescribing new controlled drugs.  Thus, under 
New York’s proposed law, if a patient previously received a month’s supply of a 
controlled drug from a prescriber, a new prescriber will have access to, and will be 
required to review, that information before prescribing the patient the same or a new 
controlled drug.253 Because mandatory OARRS monitoring only provides 
information to physicians, it cannot prevent abuse where physicians willfully ignore 
this information.   
While amending Section 4729.80(A)(5) and sections of the Ohio Administrative 
Code is a step in the right direction, it is naïve in that the solution anticipates all 
physicians will only prescribe medically necessary controlled medications to their 
patients. Thus, mandatory reporting is ineffective in situations where a physician and 
patient work together to feed a patient’s addiction. A well-known example is the 
previously mentioned death of Michael Jackson.254  The medications that caused 
Jackson’s death were prescribed and administered by his personal physician,255 who 
was found guilty of involuntary manslaughter.256   
                                                            
 251 New York Passed Legislation Requiring E-Prescribing Software, DAW SYSTEMS, INC. 
(June 29, 2012), http://dawsystems.com/news/e-prescribing-legal-news/new-york-passed-
legislation-requiring-e-prescribing-software/ (“This is the first state in the country to mandate 
that doctors observe patient's medical history and previous prescriptions before assigning 
schedule II, III or IV controlled substances.”). 
 252 See Dan Herbeck, Welcoming Legal Remedy to Prescription Drug Nightmare, BUFFALO 
NEWS (Jul. 12, 2012, 12:05 AM), http://www.accessmylibrary.com/article-1G1-
296348490/welcoming-legal-remedy-prescription.html; see also Internet System For Tracking 
Over-Prescribing Act S-7637-2011(D)(2), NYSENATE.GOV, http://open.nysenate.gov/legis 
lation/bill/S7637-2011 (last visited Dec. 4, 2012); New York Passed Legislation Requiring E-
Prescribing Software, supra note 251 (noting that state legislators passed I-STOP in June, 
2012). 
 253 See Internet System For Tracking Over-Prescribing Act S-7637-2011(D)(2), supra note 
252. 
 254 See supra Part II.A.2 (discussing Michael Jackson’s death that was caused by 
tranquilizers). 
 255 See Wedro, supra note 63.  
 256 See Karen Grigsby Bates, Jury Finds Dr. Murray Guilty in Pop Star’s Death, NPR 
(Nov. 8, 2011), http://www.npr.org/2011/11/08/142123505/jury-finds-dr-murray-guilty-in-
pop-stars-death; see also Alan Duke, Conrad Murray Sentenced to Four Years Behind Bars, 
CNN (Nov. 30, 2011, 5:46 AM), http://www.cnn.com/2011/11/29/justice/california-conrad-
murray-sentencing/index.html (reporting that Dr. Murray, the doctor who prescribed the drugs 
that killed Michael Jackson, was sentenced to prison for four years). 
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Still, despite some of the limitations of mandatory OARRS reporting, such 
reporting has additional benefits outside the scope of preventing prescription abuse.  
For example, a specialist could have access to a patient’s controlled medication 
history for the last two years.257 This would allow this physician to make decisions in 
the best interest of the patient by prescribing medications based on potential drug 
interactions. In a similar vein, physicians in emergency rooms will have complete 
prescription information on a patient that they are treating.258 Having such 
information would lead to better healthcare for all patients.  Despite the benefits of 
mandatory OARRS reporting, practitioners still would only have access to patient 
prescription information from Ohio. 
2.  Interstate OARRS Connectivity 
Under today’s system, mandatory OARRS reporting will not likely prevent 
prescription abuse where patients receive drugs in another state.  Currently, OARRS 
can only interact with the prescription databases in nine other states.259  Thus, 
physicians can only see the medications a patient receives in those states.260   
To make mandatory prescription reporting truly effective, OARRS should 
communicate with the prescription databases of all states.261  Currently, there is no 
single database that handles a prescription-monitoring program (“PMP”).262 Thus, it 
would seemingly be challenging and expensive to make the database of one state 
communicate with the database of another state.263 Currently, OARRS can interface 
with the PMPs of Arizona, Connecticut, Indiana, Kansas, Mississippi, North Dakota, 
South Carolina, Virginia, and West Virginia.264 Noticeably missing from this list is 
Kentucky, Pennsylvania, and Michigan, which share a border with Ohio.  Patients 
living in a southern Ohio city, such as Portsmouth, could have prescriptions filled in 
Kentucky and OARRS would not be able to report this information. Even though 
Ohio eliminated pill mills with the enactment of H.B. 93, patients can still go to an 
out of state pill mill to obtain controlled medications such as Oxycontin. Ohioans 
can depend on out of state pill mills because Ohio’s law enforcement agencies, and 
                                                            
 257 See supra, Part III.B.1–2. 
 258 See supra, Part III.B.1–2. 
 259 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161.  
 260 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161.  
 261 See supra Part III.B.1 (discussing the limitations of a prescription database that cannot 
interact with the prescription databases of other states).  
 262 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161. While not directly stated, this can be inferred because OARRS is 
able to interact with the databases from only nine other states.  If there was a single database 
that managed this process, OARRS would likely interact with more than just nine other states. 
 263 See Ohio Deploys NABP PMP InterConnect Statewide, Arizona Signs On to 
Participate, supra note 161. 
 264 See infra Part III.C.2 (proposing that OARRS should interact with the PMPs of other 
states). 
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more importantly, the Ohio patient’s physician, would be oblivious to the 
medications a patient receives out of state.   
Because of the limitations of the current system, the Ohio legislature should 
appropriate resources to Ohio’s Board of Pharmacy, which manages OARRS.265 
Currently, OARRS is funded entirely by federal grants.266  With these additional 
state resources, the Pharmacy Board could fully utilize OARRS by interacting with 
the PMPs of other states, such as Kentucky’s KASPER.267 Interacting Kentucky’s 
PMP system with Ohio OARRS system is especially important not only because 
Kentucky has similar prescription abuse problems as Ohio, but also because 
Kentucky shares a border with Ohio.268 Interstate connectivity of prescription 
databases would prevent doctor shoppers living near state borders from filling 
prescriptions in multiple states, unbeknownst to authorities. Promoting interstate 
reporting would also add teeth to Ohio’s 2925.22, which can only prevent “deceit” in 
Ohio and nine other states with whom OARRS connects with.269 While interstate 
OARRS reporting would be beneficial, it is not a cure-all for Ohio’s “interstate 
doctor shopping” problem, unless each state similarly required physicians to use 
their respective databases to report controlled medications prescribed to patients.270 
Thus, amending Section 4729.80(A)(5), as proposed in the previous section, would 
only be as effective as other states’ stances on prescription drug abuse.271 
                                                            
 265 OHIO REV. CODE ANN. § 4729.75 (LexisNexis 2011) (“The state board of pharmacy may 
establish and maintain a drug database. The board shall use the drug database to monitor the 
misuse and diversion of controlled substances. . .”). 
 266 See Winsley & Droz, supra note 234.  
 267 KASPER (Kentucky All Schedule Prescription Electronic Reporting), KENTUCKY 
CABINET FOR HEALTH AND FAMILY SERVICES, http://chfs.ky.gov/os/oig/KASPER.htm (last 
updated Sept. 21, 2012); see also Leger, supra note 157. While Ohio and Kentucky have a 
memorandum of understanding, the prescription monitoring programs of these states do not 
yet communicate with each other. Id. 
 268 See generally Politicians, Physicians Should Lead Fight Against Ky. Pill Mills, supra 
note 216 (describing the problems Kentucky faces with pill mills); cf. Tavernise, supra note 2 
(describing the havoc wrought in Southern Ohio by pill mills). 
 269 See supra Part III.B.1 (describing the shortcomings of Ohio’s “doctor shopper” statute). 
 270 E.g., KY REV. STAT. ANN. § 218A.202(3) (LexisNexis 2011) (showing that similar to 
Ohio, Kentucky requires only dispensers and not prescribers to report prescription data to 
KASPER; but OARRS cannot share information with KASPAR because there is no 
memorandum of understanding); 28 PA. CODE § 25.131 (Lexis Nexis 2011) (showing that 
Pennsylvania only requires pharmacies to report on Schedule II substances like Oxycontin, but 
not Schedule III to V substances);  IN. CODE ANN. § 35-48-7-8.1 (LexisNexis 2011) (showing 
that similar to Ohio, Indiana requires only dispensers and not prescribers to report prescription 
data to INSPECT); MICH. ADMIN. CODE R. 338.3162d (LexisNexis 2011) (showing that 
similar to Ohio, Michigan requires only dispensers and not prescribers to report prescription 
data to its prescription monitoring program; but OARRS cannot share information with 
Michigan’s database because there is no memorandum of understanding); see also Ohio 
Deploys NABP PMP InterConnect Statewide, Arizona Signs On to Participate, supra note 161 
(listing the different states that OARRS can interact with, included in the list is Indiana). 
 271 See supra Part III.C.1 (proposing that Ohio legislature amend Section 4729.80(A)(5) to 
require all physicians to report controlled medications prescribed to patients to OARRS); see 
generally, Interstate Sharing of Prescription Monitoring Database Information, NATIONAL 
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3.  Unused Prescription Collections 
A third solution to help curb prescription drug abuse would be to “take back” 
unused prescription medications.272 The DEA currently has a program to collect 
unused medications.273 The premise of this program is that the DEA will host 
collection centers for people to bring their unused prescriptions to get these drugs off 
of the street.274 The DEA will then destroy the medications in a safe way.275  Ohio 
has established a similar drug “take back” program under House Bill 93.276  The 
effectiveness of this newly established program in removing excess prescription 
drugs from the street remains to be seen. Recent drug “take back” programs have had 
promising results as did one in Cleveland, Ohio where over four tons of medications 
were collected.277  Where community resources are limited, commentators have 
proposed retail pharmacy-based programs, where patients would be more likely to 
return medications.278  The pharmacy would then turn these drugs into the DEA for 
destruction. 
Removing prescription drugs from the street would reduce the instances of 
prescription drug abuse originating in the home.279  While this will not stop the abuse 
problem entirely, because not all persons will turn in their unused medications, 
decreasing the amount of drugs on the street will certainly help to curb abuse. 
4.  Anti-Doctor Shopper Statute 
The Ohio legislature should also effectively punish the act of doctor shopping.  
Ohio currently does not effectively criminalize the act of obtaining prescriptions 
through fraud.280  While most of this Note advocates prevention-oriented legislation, 
backward looking statutes can also effectively prevent drug abuse if used properly.  
                                                            
ALLIANCE FOR MODEL STATE DRUG LAWS (Oct. 17, 2011), available at http://www.namsdl 
.org/documents/InterstateSharingofPMPInformation10.14.2011.pdf (surveying the enabling 
prescription monitoring program laws of various states). 
 272 See supra Part III. 
 273 National Take Back Initiative, OFFICE OF DIVERSION CONTROL, DRUG ENFORCEMENT 
AGENCY, http://www.deadiversion.usdoj.gov/drug_disposal/takeback/index.html (last visited 
Dec. 4, 2012). 
 274 See id.; Donaldson, supra note 134. 
 275 See Donaldson, supra note 134. 
 276 See OHIO REV. CODE ANN. § 4729.69(A) (LexisNexis 2011) (“The state board of 
pharmacy, in collaboration with the director of alcohol and drug addiction services and 
attorney general, shall establish and administer a drug take-back program under which drugs 
are collected from the community for the purpose of destruction or disposal of the drugs.”). 
 277 See Donaldson, supra note 134. 
 278 See Robert J. Greenwood, Commentary on “Drug Take-Back Programs Are Safe, 
Clean”, NCPANET.ORG, http://www.ncpanet.org/index.php/ncpa-commentary/913-
commentary-on-qdrug-take-back-programs-are-safe-cleanq (last visited Dec. 4, 2012); Issues, 
THE DRUG TAKE-BACK NETWORK, http://www.takebacknetwork.com/issues.html (last visited 
Dec. 4, 2012). 
 279 See generally supra Part II.D.3 (identifying dangers of prescriptions found in the home). 
 280 See supra Part III.B.1 (discussing Ohio’s § 2925.22 and its ineffectiveness). 
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Specifically, an anti-doctor shopper statute used in conjunction with mandating 
physician OARRS reporting for controlled medications can be a useful tool to 
prevent prescription abuse.281  In this way, Ohio can prevent prescription abuse that 
is initiated by a patient. 
Florida currently criminalizes the act of obtaining prescriptions through fraud.282  
The Florida statute differs from Ohio’s Section 2925.22 in that it specifically 
prevents patients from doctor shopping.283  Florida’s Section 893.13(7)(a)(8) 
mandates that a patient cannot withhold that they “received a controlled substance or 
a prescription for a controlled substance of like therapeutic use from another 
practitioner within the previous 30 days.”284  Further, “withholding” has been 
interpreted to mean “hold back,” as such a patient must volunteer to a prescriber that 
they recently received a controlled medication from a different prescriber, regardless 
of whether the prescriber specifically asks for this information.285  Although 
Florida’s doctor shopping statute criminalizes this activity, it would be difficult to 
enforce in Ohio under the current statutory system.286  Without a mandatory 
reporting requirement, physicians would only know that their patients are shopping 
if the physicians happened to run a report on their patients.  Accordingly, if Ohio 
were to enact legislation similar to Florida’s Section 893.13(7)(a)(8), it would only 
be truly effective if the burden was on the prescribers and patients. Effective 
legislation would require a prescriber’s burden to run reports up front and a patient’s 
burden to affirmatively disclose all medications they were taking before receiving a 
prescription for controlled medications. 
D.  Debunking the Criticism of OARRS by Practitioners and Patients 
Despite the potential wealth of information OARRS contains, healthcare 
professionals cite many reasons as to why they choose not use these reports.  Some 
critics point to the burden of running OARRS reports on patients.287 Others are 
                                                            
 281 See generally supra Part III.C.1 (proposing that Ohio mandate OARRS reporting for 
controlled medications). 
 282 FLA. STAT. ANN. § 893.13(7)(a)(8)–(9) (LexisNexis 2011). 
 283 Knipp v. State, 67 So. 3d 376, 379 (Fla. Dist. Ct. App. 4th Dist. 2011) (interpreting that 
a patient’s failure to affirmatively disclose prior requests to receive a controlled medication is 
a violation of section 893.13(7)(a)(8)). But cf. OHIO REV. CODE ANN. § 2925.22(A) 
(LexisNexis 2011) (“[n]o person, by deception, shall procure . . . a dangerous drug . . . .”); 
State v. O'Connell, 2011-Ohio-652, ¶3 (Ohio Ct. App. 2011) ; State v. Hartney, 2010-Ohio-
4331, ¶¶2-3 (Ohio Ct. App. 2010); State v. Newland, 2009-Ohio-1340, ¶¶2-4 (Ohio Ct. App. 
2009) (finding deception shown where patient affirmatively lied about medications she was 
taking.). 
 284 FLA. STAT. ANN. § 893.13(7)(a)(8) (LexisNexis 2011).  
 285 Knipp, 67 So. 3d at 379 (“Whether an individual has actually withheld information in 
violation of the statute depends on whether s/he requested a controlled substance and failed to 
disclose the fact that s/he received a drug of like therapeutic use within the previous thirty 
days. In other words, the statute requires that an individual affirmatively requesting a 
substance provide information to the practitioner.”). 
 286 See supra Part III.B.1 (discussing inadequacy of statute in regards to doctor shopping). 
 287 Cf. Zimmer, supra note 20 (“doctors have issues with the cumulative time commitment 
of system checks. Others have criticized [the system] for the lag time between when a 
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concerned with the privacy issues of maintaining a patient database filled with 
information relating to a patient’s healthcare.288  As shown below, these criticisms 
are either untenable or do not outweigh the benefit of having such a system in place. 
Some criticize the slow response time it takes to run a report, and thus the 
argument follows that physicians have less time to effectively treat patients.289  But, 
in 2006 (the inception of OARRS), the average time needed to run a report on a 
patient was 30 seconds.290   By 2011, the time had decreased to just 3 seconds per 
request.291  In fact, the State Board of Pharmacy has noted in their report to the Ohio 
legislature, after the enactment of H.B. 93, that when OARRS users complain of the 
difficulty in accessing OARRS most of their complaints stem from user errors, such 
as: difficulty connecting to the internet, difficulty logging on to the website, and 
other technical issues, such as the speed of the user’s computer or the network 
speed.292  In order to address some of these shortcomings, the Ohio Board of 
Pharmacy has begun working with two large pharmacy systems to see if OARRS 
can be integrated into both the workflow and software of the user’s system.293 
Some physicians are concerned with the administrative burden of referencing an 
online patient database before prescribing a medication to a patient. 294  This criticism 
is moot, however, because House Bill 93 grants medical support professionals the 
ability to access OARRS.295  Further, the Ohio Board of Pharmacy has reported that 
now 99.5% of requested reports process in less than three seconds.296  Others 
maintain that such an online database is unnecessary because physicians are in the 
best position to evaluate their patients and determine what medications, if any, are in 
                                                            
prescription is filled and when that activity actually appears in the database.”); Tribble, supra 
note 113 (arguing reporting “would hit doctors at a time when they are seeing more patients 
and implementing their own electronic medical records. Doctors receive training on what to 
look for and how to evaluate potential patients who are doctor shopping for dangerous pain 
medications. . .”). 
 288 See Sharon Woods Harris, Drug Databases Raises Privacy Concerns, PEKIN TIMES 
(Mar. 14, 2009 10:00 AM), http://www.pekintimes.com/news/x679797701/Drug-database-
raises-privacy-concerns; see also Bill Sizemore, Hacking of Prescription Database May Lead 
to Headaches, THE VIRGINIAN PILOT (May 8, 2009), available at http://web.archive.org/web 
/20100213023552/http://www.pekintimes.com/news/x679797701/Drug-database-raises-
privacy-concerns. 
 289 Zimmer, supra note 20. 
 290 OHIO STATE BOARD OF PHARMACY, supra note 22. 
 291 OHIO STATE BOARD OF PHARMACY, supra note 22. 
 292 OHIO STATE BOARD OF PHARMACY, supra note 22. 
 293 OHIO STATE BOARD OF PHARMACY, supra note 22.  
 294 Tribble, supra note 113. 
 295 See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the 
prescriber the ability to request reports from OARRS); see supra Part III.A (describing 
positive changes of H.B. 93, one of which is to provide OARRS access to medical support 
staff). 
 296 See Winsley & Droz, supra note 234. 
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their patient’s best interest.297 OARRS does not retroactively prescribe medication 
for a patient, but instead only gives additional information to physicians to make 
better, more informed choices.298 
Some critics of the online database are also concerned with storing personal 
medical information on a central database and the accompanying vulnerability of 
patients’ privacy.299  These critics point to various issues, including a patient’s right 
to disclose personal medical information and the external threat of hackers.300  As to 
the first issue, some patients wish to compartmentalize their personal medical 
information.301  For example, patients may not be comfortable with a specialist 
accessing their complete prescription medical history over a two-year period, which 
may include problems unrelated to the patient’s treatment.302  This concern to keep 
information private, however, does not justify the risks.  On a micro level, 
physicians need all relevant information about their patients’ medical history, 
including a list of the medications they are taking, to provide the best care 
compatible with the patient’s prior treatments and medications.  On a macro level, 
ending PMPs because some patients may not want physicians to know what 
medications they are taking intensifies the problems with our current system in 
which physicians are unable to determine the breathe of medications their patients 
are taking. 
Critics also cite computer hackers as another privacy concern.303  These critics 
point to the Virginia pharmacy database security breach as a worst-case scenario.304  
In Virginia, a hacker accessed the state’s online patient database and copied eight 
million entries on personal medical information.305  The hacker then deleted the 
Virginia database, and subsequently encrypted the copy that he kept for himself, 
                                                            
 297 Tribble, supra note 113 (“Doctors receive training on what to look for and how to 
evaluate potential patients who are doctor shopping for dangerous pain medications.”). 
 298 STATE MEDICAL BOARD OF OHIO, IMPROVING PATIENT CARE THROUGH ENHANCED USE 
OF OARRS 1, available at https://www.ohiopmp.gov/Portal/images/MedBoardArticle.pdf 
(“OARRS prescription history reports are an important component of delivering and 
coordinating patient-centered care . . . Prescription history reports . . . assist providers in better 
management of a patient’s prescription regimen . . .”). 
 299 See Harris, supra note 288; Sizemore, supra note 288.  
 300 See Harris, supra note 288; see also Sizemore, supra note 288 (a group of legislators 
asked the Florida governor to veto a new prescription database, citing the Virginia incident). 
 301 See generally Harris, supra note 288. Although this Article discusses privacy in the 
context of law enforcement access to a prescription database, patients may be similarly 
apprehensive to allow other healthcare professionals to access the database. 
 302 See Harris, supra note 288. 
 303 See Sizemore, supra note 288.  
 304 See Sizemore, supra note 288. 
 305 Ira Winkler, The Virginia PMP Hack: ‘Burn After Reading’, INTERNET EVOLUTION, 
(May 13, 2009), http://www.internetevolution.com/author.asp?section_id=515&doc_id 
=176649; Bryan Boughton, et al, FBI Probes Hacker's $10 Million Ransom Demand for 
Stolen Virginia Medical Records, FOXNEWS.COM (May 7, 2009), http://www.foxnews. 
com/story/0,2933,519187,00.html. 
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preventing the state from obtaining the information.306  The hacker finally posted a 
ransom note, demanding $10 million for the password to decrypt the database.307 
While the situation in Virginia was unfortunate, it was also preventable.  First, 
the prescription database was not encrypted.308  If this file had been encrypted, risks 
would have been mitigated because most hackers could not have easily opened the 
file the hacker in Virginia downloaded.309  Also, storing copies of the database 
offsite would mitigate the damage caused by hackers attacking the website.310  As 
soon as the database is taken offline, it can be restored through a comprehensive 
disaster-recovery plan.311  Fortunately, Virginia maintained database copies, and it 
was brought back online within a few days.312 Such precautionary measures 
demonstrate that prescription databases, such as OARRS, can be safe tools when the 
proper security measures are put in place. 
As demonstrated above, there are many tenable concerns with implementing a 
centralized database to store patient prescription information.313  While the risks are 
note-worthy, such risks do not justify continuing to permit prescribers to exercise 
discretion in deciding whether to run reports.  Further, some criticisms are no longer 
an issue after the enactment of H.B. 93 and the solution this Note proposes.314  
                                                            
 306 See Winkler, supra note 305. 
 307 See Winkler, supra note 305; Brian Krebs, Hackers Break Into Virginia Health 
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 308 See Winkler, supra note 305.  
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programming/comments/9pu3k/how_long_would_it_take_to_bruteforce_crack_an_aes/ (last 
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perform approximately 255 operations to open an encrypted drive.  A government 
supercomputer that cost $250,000 took 56 hours to do this in 1998.  Moore’s Law 
hypothesizes that a modern super computer costing $1 million could crack a 12-character 
password in 7 minutes.). 
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 314 See OHIO REV. CODE ANN. § 4729.80(A)(5) (LexisNexis 2011) (providing agents of the 
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Finally, privacy issues regarding hackers can be mitigated with proper security 
measures, as shown in Virginia case.315  Accordingly, Ohio needs to embrace 
OARRS as a tool to combat prescription abuse, instead of vilifying it as a source of 
liability. 
IV.  CONCLUSION 
Prescription medications undoubtedly have an essential role in healthcare. As 
demonstrated by the recent prescription abuse epidemics in Portsmouth, Ohio and 
heroin deaths in Ohio’s suburbs, these medications are still dangerous, can lead to 
the abuse of more serious drugs, and should be treated with the respect they 
deserve.316  Thus, Ohio should mandate the use of OARRS reporting by all 
physicians, increase the capacity of OARRS to interact with prescription databases 
from other states, better promote drug “take back” programs, and enact stronger anti-
doctor shopper statutes.317  While these ideas are not a panacea to curbing all 
prescription drug abuse, it will force the gatekeepers of controlled medications to 
think twice before they dispense medications.  Implementing these initiatives will 
provide physicians the information necessary to make educated decisions about the 
best medications to prescribe their patients.  Additionally, these changes will remove 
dangerous prescriptions from the streets, which inevitably lead to the slippery slope 
of more serious illicit drug abuse.318  These solutions will restrict the home and 
physician’s offices as major sources of prescription drugs, and thus help contain the 
problems of prescription drug abuse. 
 
                                                            
 315 See supra Part III.D (describing Virginia incident, which highlighted the importance of 
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 316 See Tavernise, supra note 2 (describing Portsmouth’s plight with prescription pain-
killers); See Carloss, supra note 129 (describing recent heroin epidemic in Independence, 
Ohio); See generally supra Part II (describing the dangers of prescription medications and the 
slippery slope to more serious prescription abuse). 
 317 See generally supra Part III.C (asserting that Ohio should make changes to its current 
statutory system, including mandating the use of OARRS reporting by all physicians, 
increasing the capacity of OARRS to interact with prescription databases from other states, 
better promoting drug take back programs, and enacting stronger anti-doctor shopper statutes). 
 318 See generally supra Part II.D.2 (describing the slippery slope of prescription drug abuse 
into more serious illegal drugs); supra Part III.C.3 (asserting that Ohio should better promote 
drug take back programs to remove excess pills from the street). 
